commit 4a84d9e90bb507ce17a52f782689062056a98175
Author: davidlagorce <david.lagorce@inserm.fr>
Date:   Tue Jul 2 21:30:06 2024 +0200

    JULY 2024

diff --git a/Epidemiological data/Rare disease epidemiology/de_product9_prev.xml b/Epidemiological data/Rare disease epidemiology/de_product9_prev.xml
index 2df56c9..4211cbc 100644
--- a/Epidemiological data/Rare disease epidemiology/de_product9_prev.xml	
+++ b/Epidemiological data/Rare disease epidemiology/de_product9_prev.xml	
@@ -1,5 +1,5 @@
 <?xml version="1.0" encoding="ISO-8859-1"?>
-<JDBOR date="2023-12-04 08:18:49" version="1.3.29 / 4.1.7 [2023-08-02] (orientdb version)" copyright="Orphanet (c) 2023" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
+<JDBOR date="2024-07-01 09:18:54" version="1.3.29 / 4.1.7 [2023-08-02] (orientdb version)" copyright="Orphanet (c) 2024" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
   <Availability> 
     <Licence>
       <FullName lang="en">Creative Commons Attribution 4.0 International</FullName>
@@ -7,11 +7,11 @@
       <LegalCode>https://creativecommons.org/licenses/by/4.0/legalcode</LegalCode>
     </Licence>
   </Availability>
-  <DisorderList count="6088">
+  <DisorderList count="6076">
     <Disorder id="17601">
       <OrphaCode>166024</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=166024</ExpertLink>
-      <Name lang="de">Dysplasie, epiphysäre multiple, Typ Al-Gazali</Name>
+      <Name lang="de">Multiple epiphysäre Dysplasie-Makrozephalie-Gesichtsdysmorphie-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -111,7 +111,7 @@
     <Disorder id="17603">
       <OrphaCode>166032</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=166032</ExpertLink>
-      <Name lang="de">Dysplasie, epiphysäre multiple, mit Miniepiphysen</Name>
+      <Name lang="de">Multiple epiphysäre Dysplasie-Miniepiphysen-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -306,7 +306,7 @@
     <Disorder id="17602">
       <OrphaCode>166029</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=166029</ExpertLink>
-      <Name lang="de">Dysplasie, epiphysäre multiple, mit schwerer proximaler Femur-Dysplasie</Name>
+      <Name lang="de">Multiple epiphysäre Dysplasie-schwere proximale Femur-Dysplasie-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -568,17 +568,17 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="13">
-          <Source>36980153[PMID]_37732042[PMID]_ORPHANET</Source>
+          <Source>33144036[PMID]</Source>
           <PrevalenceType id="23669">
             <Name lang="de">Punktprävalenz</Name>
           </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="de">Unbekannt</Name>
+          <PrevalenceClass id="23739">
+            <Name lang="de">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
+          <ValMoy>0.2</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="de">Weltweit</Name>
           </PrevalenceGeographic>
@@ -3378,7 +3378,7 @@
     <Disorder id="17626">
       <OrphaCode>166272</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=166272</ExpertLink>
-      <Name lang="de">Goldblatt-Syndrom</Name>
+      <Name lang="de">Odontochondrodysplasia</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -3554,7 +3554,7 @@
     <Disorder id="17627">
       <OrphaCode>166277</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=166277</ExpertLink>
-      <Name lang="de">Skelettdysplasie mit Wormschen Knochen-multiplen Frakturen-Dentinogenesis imperfecta-Syndrom</Name>
+      <Name lang="de">Wormsche Knochen-multiplen Frakturen-Dentinogenesis imperfecta-Skelettdysplasie-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -12133,55 +12133,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="17598">
-      <OrphaCode>166011</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=166011</ExpertLink>
-      <Name lang="de">Dysplasie, epiphysäre multiple, Typ Beighton</Name>
-      <DisorderType id="21394">
-        <Name lang="de">Krankheit</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="8320">
-          <Source>699354[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="de">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23725">
-            <Name lang="de">Family</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>1.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8321">
-          <Source>ORPHANET_699354[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="126">
       <OrphaCode>567</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=567</ExpertLink>
@@ -15957,7 +15908,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="10703">
           <Source>19289752[PMID]</Source>
           <PrevalenceType id="23676">
@@ -15977,6 +15928,25 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17561">
+          <Source>32141953[PMID]_35359921[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="de">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.4805</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="de">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="158">
@@ -16186,7 +16156,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="4">
         <Prevalence id="581">
           <Source>12088082[PMID]</Source>
           <PrevalenceType id="23683">
@@ -16225,6 +16195,44 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17537">
+          <Source>12088082[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="de">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>13.3</ValMoy>
+          <PrevalenceGeographic id="25006">
+            <Name lang="de">Norway</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17538">
+          <Source>14967851[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="de">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>4.2</ValMoy>
+          <PrevalenceGeographic id="24537">
+            <Name lang="de">Hong Kong</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="147">
@@ -17074,7 +17082,7 @@
     <Disorder id="17514">
       <OrphaCode>163649</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=163649</ExpertLink>
-      <Name lang="de">Dysplasie, spondyloepiphysäre, Typ Nishimura</Name>
+      <Name lang="de">Spondyloepiphysäre Dysplasie-Kraniosynostose-Gaumenspalte Katarakt-Intelligenzminderung-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -17243,7 +17251,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="4">
+      <PrevalenceList count="5">
         <Prevalence id="637">
           <Source>11949733[PMID]_[EXPERT]</Source>
           <PrevalenceType id="23676">
@@ -17320,6 +17328,25 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17511">
+          <Source>9724012[PMID]_11949733[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="de">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>3.8</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="de">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="168">
@@ -17569,7 +17596,7 @@
     <Disorder id="173">
       <OrphaCode>394</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=394</ExpertLink>
-      <Name lang="de">Homocystinurie, klassische</Name>
+      <Name lang="de">Homocystinurie durch Cystathionin-beta-Synthase-Mangel</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -18513,7 +18540,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="8297">
           <Source>PMID: 22911482</Source>
           <PrevalenceType id="23676">
@@ -18533,6 +18560,25 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17565">
+          <Source>28898171[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="24418">
+            <Name lang="de">Germany</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="190">
@@ -23348,7 +23394,7 @@
     <Disorder id="277">
       <OrphaCode>2443</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2443</ExpertLink>
-      <Name lang="de">Mitochondriale Krankheiten, nukleären Ursprungs</Name>
+      <Name lang="de">Mitochondriale Störung der oxidativen Phosphorylierung durch Anomalien der nukleären DNA</Name>
       <DisorderType id="36561">
         <Name lang="de">Kategorie</Name>
       </DisorderType>
@@ -23959,7 +24005,7 @@
     <Disorder id="257">
       <OrphaCode>1646</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1646</ExpertLink>
-      <Name lang="de">Chromosom Y-Deletion, partielle</Name>
+      <Name lang="de">Chromosom Y-Mikrodeletion</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -25532,8 +25578,8 @@
       <OrphaCode>308</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=308</ExpertLink>
       <Name lang="de">Epilepsie, myoklonische progressive, Typ 1</Name>
-      <DisorderType id="21401">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
+      <DisorderType id="21394">
+        <Name lang="de">Krankheit</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
@@ -26196,7 +26242,7 @@
     <Disorder id="343">
       <OrphaCode>1727</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1727</ExpertLink>
-      <Name lang="de">Mikroduplikationssyndrom 22q11.2</Name>
+      <Name lang="de">22q11.2-Duplikationssyndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -28196,7 +28242,7 @@
     <Disorder id="17807">
       <OrphaCode>168966</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=168966</ExpertLink>
-      <Name lang="de">Kombinationslymphom</Name>
+      <Name lang="de">Komposit-Lymphom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -29265,7 +29311,7 @@
     <Disorder id="367">
       <OrphaCode>610</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=610</ExpertLink>
-      <Name lang="de">Bethlem-Myopathie</Name>
+      <Name lang="de">Bethlem-Muskeldystrophie</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -30977,7 +31023,7 @@
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=168615</ExpertLink>
       <Name lang="de">Hereditäre Persistenz des Alpha-Fetoproteins</Name>
       <DisorderType id="21408">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
+        <Name lang="de">Biologische Anomalie</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
@@ -31026,7 +31072,7 @@
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=168612</ExpertLink>
       <Name lang="de">Alpha-Fetoprotein-Mangel, kongenitaler</Name>
       <DisorderType id="21408">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
+        <Name lang="de">Biologische Anomalie</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
@@ -31221,38 +31267,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="444">
-      <OrphaCode>1455</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1455</ExpertLink>
-      <Name lang="de">Aortenisthmusstenose, dominante</Name>
-      <DisorderType id="21450">
-        <Name lang="de">Klinischer Subtyp</Name>
-      </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="de">Subtyp der Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="1105">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="de">Unbekannt</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="de">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="17788">
       <OrphaCode>168624</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=168624</ExpertLink>
@@ -33011,277 +33025,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="17765">
-      <OrphaCode>168486</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=168486</ExpertLink>
-      <Name lang="de">Ceroid-Lipofuszinose, neuronale, kongenitale</Name>
-      <DisorderType id="21394">
-        <Name lang="de">Krankheit</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="8367">
-          <Source>16670177[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="de">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="de">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>10.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8368">
-          <Source>ORPHANET_16670177[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
-    <Disorder id="17766">
-      <OrphaCode>168491</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=168491</ExpertLink>
-      <Name lang="de">Ceroid-Lipofuszinose, neuronale, spät-infantile</Name>
-      <DisorderType id="21394">
-        <Name lang="de">Krankheit</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="11">
-        <Prevalence id="8369">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23683">
-            <Name lang="de">Prävalenz bei Geburt</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="de">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="de">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8370">
-          <Source>1609834[PMID]_[EXPERT]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="de">Prävalenz bei Geburt</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.46</ValMoy>
-          <PrevalenceGeographic id="24418">
-            <Name lang="de">Germany</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8371">
-          <Source>23374165[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="de">Prävalenz bei Geburt</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.78</ValMoy>
-          <PrevalenceGeographic id="24607">
-            <Name lang="de">Italy</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8372">
-          <Source>9151309[PMID]_[EXPERT]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="de">Prävalenz bei Geburt</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="de">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>5.0</ValMoy>
-          <PrevalenceGeographic id="24362">
-            <Name lang="de">Finland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8373">
-          <Source>9151309[PMID]_[EXPERT]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.26</ValMoy>
-          <PrevalenceGeographic id="24362">
-            <Name lang="de">Finland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8374">
-          <Source>9151309[PMID]_[EXPERT]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="de">Prävalenz bei Geburt</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="25335">
-            <Name lang="de">Sweden</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8375">
-          <Source>9151309[PMID]_[EXPERT]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.06</ValMoy>
-          <PrevalenceGeographic id="25335">
-            <Name lang="de">Sweden</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8376">
-          <Source>18684116[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="de">Prävalenz bei Geburt</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="de">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>9.0</ValMoy>
-          <PrevalenceGeographic id="24124">
-            <Name lang="de">Canada</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8377">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="de">Unbekannt</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="de">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10739">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.07</ValMoy>
-          <PrevalenceGeographic id="25006">
-            <Name lang="de">Norway</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10740">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.38</ValMoy>
-          <PrevalenceGeographic id="24551">
-            <Name lang="de">Iceland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="17767">
       <OrphaCode>168544</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=168544</ExpertLink>
@@ -34251,7 +33994,7 @@
     <Disorder id="456">
       <OrphaCode>217</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=217</ExpertLink>
-      <Name lang="de">Dandy-Walker-Malformation, isolierte</Name>
+      <Name lang="de">Dandy-Walker-Fehlbildung, isolierte</Name>
       <DisorderType id="21415">
         <Name lang="de">Morphologische Anomalie</Name>
       </DisorderType>
@@ -34351,7 +34094,7 @@
     <Disorder id="450">
       <OrphaCode>1538</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1538</ExpertLink>
-      <Name lang="de">Kraniosynostose - Dandy-Walker-Malformation - Hydrozephalus</Name>
+      <Name lang="de">Kraniosynostose-Dandy-Walker-Fehlbildung-Hydrozephalus-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -40468,7 +40211,7 @@
     <Disorder id="530">
       <OrphaCode>2374</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2374</ExpertLink>
-      <Name lang="de">Larynxnetz, kongenitales</Name>
+      <Name lang="de">Larynxnetz, isoliertes kongenitales</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -46190,7 +45933,7 @@
     <Disorder id="606">
       <OrphaCode>1422</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1422</ExpertLink>
-      <Name lang="de">Chondrodysplasie-Störung der Geschlechtsentwicklung-Syndrom</Name>
+      <Name lang="de">Chondrodysplasie-Variante der Geschlechtsentwicklung-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -50280,7 +50023,7 @@
     <Disorder id="17999">
       <OrphaCode>178029</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=178029</ExpertLink>
-      <Name lang="de">Diabetes insipidus, zentraler</Name>
+      <Name lang="de">Arginin-Vasopressin-Mangel</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -53879,9 +53622,9 @@
     <Disorder id="751">
       <OrphaCode>2406</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2406</ExpertLink>
-      <Name lang="de">Locked-In-Syndrome</Name>
-      <DisorderType id="21394">
-        <Name lang="de">Krankheit</Name>
+      <Name lang="de">Locked-in-Syndrom</Name>
+      <DisorderType id="21422">
+        <Name lang="de">Klinisches Syndrom</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
@@ -64005,7 +63748,7 @@
     <Disorder id="18404">
       <OrphaCode>199337</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=199337</ExpertLink>
-      <Name lang="de">Pankreasinsuffizienz - Anämie - Hyperostose</Name>
+      <Name lang="de">Pankreasinsuffizienz-Anämie-Hyperostose-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -70023,7 +69766,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="20">
+      <PrevalenceList count="21">
         <Prevalence id="2360">
           <Source>28595941[PMID]</Source>
           <PrevalenceType id="23683">
@@ -70233,6 +69976,25 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17512">
+          <Source>18681890[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="de">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>27.6</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="de">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="13922">
           <Source>28595941[PMID]</Source>
           <PrevalenceType id="23683">
@@ -75358,7 +75120,7 @@
     <Disorder id="18311">
       <OrphaCode>183707</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=183707</ExpertLink>
-      <Name lang="de">Neutrophiles Immundefekt-Syndrom</Name>
+      <Name lang="de">Infantile LAD-artige Erkrankung aufgrund RAC2-Defizienz</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -75407,7 +75169,7 @@
     <Disorder id="839">
       <OrphaCode>2314</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2314</ExpertLink>
-      <Name lang="de">Hyper-IgE-Syndrom, autosomal-dominantes</Name>
+      <Name lang="de">Hyper-IgE-Syndrom, autosomal-dominantes, durch STAT3-Mangel</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -77876,7 +77638,26 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17517">
+          <Source>[https://www.ncbi.nlm.nih.gov/books/NBK1760/]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>3.0E-4</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="17459">
           <Source>[https://www.ncbi.nlm.nih.gov/books/NBK1760/]_ORPHANET</Source>
           <PrevalenceType id="23683">
@@ -84978,7 +84759,26 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17549">
+          <Source>7977461[PMID]_37868647[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="de">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>6.1</ValMoy>
+          <PrevalenceGeographic id="25293">
+            <Name lang="de">Spain</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="13319">
           <Source>7977461[PMID]</Source>
           <PrevalenceType id="23683">
@@ -85444,7 +85244,7 @@
     <Disorder id="1255">
       <OrphaCode>931</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=931</ExpertLink>
-      <Name lang="de">Acheiropodie</Name>
+      <Name lang="de">Acheiropodie, isolierte</Name>
       <DisorderType id="21415">
         <Name lang="de">Morphologische Anomalie</Name>
       </DisorderType>
@@ -89249,7 +89049,7 @@
     <Disorder id="1293">
       <OrphaCode>973</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=973</ExpertLink>
-      <Name lang="de">Kongenitale unilaterale Fingeraplasie/-hypoplasie, excl. Daumen</Name>
+      <Name lang="de">Isolierte unilaterale Fingeraplasie/-hypoplasie, excl. Daumen</Name>
       <DisorderType id="21415">
         <Name lang="de">Morphologische Anomalie</Name>
       </DisorderType>
@@ -89762,7 +89562,7 @@
     <Disorder id="16894">
       <OrphaCode>139431</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=139431</ExpertLink>
-      <Name lang="de">Jeavons-Syndrom</Name>
+      <Name lang="de">Epilepsie mit Augenlidmyoklonie</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -89796,7 +89596,7 @@
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1035</ExpertLink>
       <Name lang="de">Beta-Mercaptolaktat-Cystein Disulfidurie</Name>
       <DisorderType id="21408">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
+        <Name lang="de">Biologische Anomalie</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
@@ -90068,38 +89868,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="16886">
-      <OrphaCode>139402</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=139402</ExpertLink>
-      <Name lang="de">Arzneimittelreaktion mit Eosinophilie und systemischen Symptomen</Name>
-      <DisorderType id="21394">
-        <Name lang="de">Krankheit</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="8128">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="de">Unbekannt</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="de">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="1335">
       <OrphaCode>1027</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1027</ExpertLink>
@@ -90149,6 +89917,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="16886">
+      <OrphaCode>139402</OrphaCode>
+      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=139402</ExpertLink>
+      <Name lang="de">Arzneimittelreaktion mit Eosinophilie und systemischen Symptomen</Name>
+      <DisorderType id="21394">
+        <Name lang="de">Krankheit</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="de">Störung</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="8128">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25965">
+            <Name lang="de">Not yet validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="16887">
       <OrphaCode>139406</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=139406</ExpertLink>
@@ -90282,7 +90082,7 @@
     <Disorder id="1323">
       <OrphaCode>1010</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1010</ExpertLink>
-      <Name lang="de">Palmoplantarkeratose - kongenitale Alopezie, autosomal-dominant</Name>
+      <Name lang="de">Autosomal-dominante Palmoplantarkeratose und kongenitale Alopezie</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -90497,7 +90297,7 @@
     <Disorder id="1316">
       <OrphaCode>1003</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1003</ExpertLink>
-      <Name lang="de">Skalpdefekte - postaxiale Polydaktylie</Name>
+      <Name lang="de">Kopfhautdefekte-postaxiale Polydaktylie-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -92570,19 +92370,19 @@
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="8056">
-          <Source>European Medicines Agency[INST]</Source>
+          <Source>32732703[PMID]_34622738[PMID]_33607690[PMID]_3391390{PMID]</Source>
           <PrevalenceType id="23669">
             <Name lang="de">Punktprävalenz</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23711">
             <Name lang="de">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="de">1-5 / 10 000</Name>
+          <PrevalenceClass id="23746">
+            <Name lang="de">1-9 / 100 000</Name>
           </PrevalenceClass>
-          <ValMoy>16.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="de">Europa</Name>
+          <ValMoy>4.2091</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="de">Validated</Name>
@@ -95894,7 +95694,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="4">
         <Prevalence id="2971">
           <Source>9714114[PMID]</Source>
           <PrevalenceType id="23683">
@@ -95933,6 +95733,44 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17539">
+          <Source>9714114[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="25475">
+            <Name lang="de">United Kingdom</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17540">
+          <Source>11515692[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="25335">
+            <Name lang="de">Sweden</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="1642">
@@ -96865,7 +96703,26 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17562">
+          <Source>32670090[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="24362">
+            <Name lang="de">Finland</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="13947">
           <Source>16892327[PMID]</Source>
           <PrevalenceType id="23683">
@@ -96936,104 +96793,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="17078">
-      <OrphaCode>141327</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=141327</ExpertLink>
-      <Name lang="de">Oro-fazio-digitales Syndrom Typ 12</Name>
-      <DisorderType id="21401">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="13442">
-          <Source>9546832[PMID]_17963220[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="de">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="de">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>1.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="13443">
-          <Source>ORPHANET_9546832[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
-    <Disorder id="17079">
-      <OrphaCode>141330</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=141330</ExpertLink>
-      <Name lang="de">Oro-fazio-digitales Syndrom Typ 13</Name>
-      <DisorderType id="21401">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="13444">
-          <Source>10683749[PMID]_17963220[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="de">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="de">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>1.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="13445">
-          <Source>ORPHANET_10683749[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="1654">
       <OrphaCode>1471</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1471</ExpertLink>
@@ -97581,7 +97340,26 @@
       <DisorderGroup id="36554">
         <Name lang="de">Subtyp der Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17523">
+          <Source>21701667[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0017</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="12871">
           <Source>ORPHANET_21701667[PMID]</Source>
           <PrevalenceType id="23683">
@@ -97839,7 +97617,26 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17558">
+          <Source>16410137[PMID]_30159250[PMID]_32851317[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="24124">
+            <Name lang="de">Canada</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="14484">
           <Source>17712567[PMID]</Source>
           <PrevalenceType id="23683">
@@ -97979,7 +97776,26 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17559">
+          <Source>ISBN-10:0867153903[OTHER]_28163490[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="de">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.16</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="de">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="13324">
           <Source>ISBN-10:0867153903[OTHER]_28163490[PMID]</Source>
           <PrevalenceType id="23683">
@@ -98332,7 +98148,7 @@
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1361</ExpertLink>
       <Name lang="de">Carnosinase-Mangel</Name>
       <DisorderType id="21408">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
+        <Name lang="de">Biologische Anomalie</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
@@ -98626,7 +98442,7 @@
     <Disorder id="17146">
       <OrphaCode>157798</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=157798</ExpertLink>
-      <Name lang="de">Serratiertes Polyposissyndrom</Name>
+      <Name lang="de">Serratiertes Polyposis-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -100254,55 +100070,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="1776">
-      <OrphaCode>1765</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1765</ExpertLink>
-      <Name lang="de">Dyschondrosteose - Nephritis</Name>
-      <DisorderType id="21401">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="3244">
-          <Source>788812[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="de">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23725">
-            <Name lang="de">Family</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>1.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="3245">
-          <Source>ORPHANET_788812[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="1777">
       <OrphaCode>1766</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1766</ExpertLink>
@@ -100975,7 +100742,7 @@
     <Disorder id="1731">
       <OrphaCode>1573</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1573</ExpertLink>
-      <Name lang="de">Hypotrichose - juvenile Makuladegeneration</Name>
+      <Name lang="de">Hypotrichose mit juveniler Makuladegeneration</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -101418,12 +101185,12 @@
     <Disorder id="1739">
       <OrphaCode>1617</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1617</ExpertLink>
-      <Name lang="de">Mikrodeletionssyndrom 2q24</Name>
-      <DisorderType id="21401">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
+      <Name lang="de">Syndrom der Entwicklungsverzögerung mit Sprachstörung, Dopa-reaktiver Dystonie und Parkinsonismus durch Mikrodeletion 2q24</Name>
+      <DisorderType id="21443">
+        <Name lang="de">Ätiologischer Subtyp</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
+      <DisorderGroup id="36554">
+        <Name lang="de">Subtyp der Störung</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="3221">
@@ -101474,7 +101241,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="3219">
           <Source>9326330[PMID]</Source>
           <PrevalenceType id="23683">
@@ -101494,6 +101261,25 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17550">
+          <Source>9326330[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="de">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>15.0</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="de">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="16907">
@@ -103552,7 +103338,7 @@
     <Disorder id="1718">
       <OrphaCode>1566</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1566</ExpertLink>
-      <Name lang="de">Dandy-Walker-Malformation-postaxiale Polydaktylie-Syndrom</Name>
+      <Name lang="de">Dandy-Walker-Fehlbildung-postaxiale Polydaktylie-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -103794,55 +103580,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="1715">
-      <OrphaCode>1562</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1562</ExpertLink>
-      <Name lang="de">Dakryozystitis-Osteopoikilose-Syndrom</Name>
-      <DisorderType id="21401">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="3194">
-          <Source>8261652[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="de">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="de">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>5.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="3195">
-          <Source>ORPHANET_8261652[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="17010">
       <OrphaCode>140963</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=140963</ExpertLink>
@@ -104208,7 +103945,7 @@
     <Disorder id="1720">
       <OrphaCode>1568</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1568</ExpertLink>
-      <Name lang="de">X-chromosomale Intelligenzminderung-Dandy-Walker-Malformation-Basalganglienkrankheit-Krämpfe-Syndrom</Name>
+      <Name lang="de">X-chromosomale Intelligenzminderung-Dandy-Walker-Fehlbildung-Basalganglienkrankheit-Krämpfe-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -104476,7 +104213,7 @@
     <Disorder id="1667">
       <OrphaCode>1495</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1495</ExpertLink>
-      <Name lang="de">Intelligenzminderung - Corpus callosum-Hypoplasie - präaurikuläre Anhängsel</Name>
+      <Name lang="de">Intelligenzminderung-Corpus callosum-Hypoplasie-präaurikuläre Anhängsel-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -105575,7 +105312,7 @@
     <Disorder id="1914">
       <OrphaCode>1970</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1970</ExpertLink>
-      <Name lang="de">Gesichtsdysmorphie - Makrozephalie - Myopie - Dandy-Walker-Malformation</Name>
+      <Name lang="de">Gesichtsdysmorphie-Makrozephalie-Myopie-Dandy-Walker-Fehlbildung-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -108058,7 +107795,7 @@
     <Disorder id="1816">
       <OrphaCode>1837</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1837</ExpertLink>
-      <Name lang="de">Ulna-Dysplasie, metaphysäre</Name>
+      <Name lang="de">Chondrodysplasie, metaphysäre, Typ Rosenberg</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -108627,7 +108364,7 @@
     <Disorder id="1794">
       <OrphaCode>1798</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1798</ExpertLink>
-      <Name lang="de">Dysostose Typ Stanescu</Name>
+      <Name lang="de">Kraniofaziale Dysostose-Diaphysenhyperplasie-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -108635,7 +108372,7 @@
         <Name lang="de">Störung</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
-        <Prevalence id="3259">
+        <Prevalence id="17480">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="de">Punktprävalenz</Name>
@@ -108757,7 +108494,7 @@
     <Disorder id="2035">
       <OrphaCode>2130</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2130</ExpertLink>
-      <Name lang="de">Hemimelie</Name>
+      <Name lang="de">Hemimelie, nicht-syndromale</Name>
       <DisorderType id="21436">
         <Name lang="de">Phenom-Gruppe</Name>
       </DisorderType>
@@ -110068,7 +109805,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="8254">
           <Source>22969141[PMID]</Source>
           <PrevalenceType id="23676">
@@ -110088,6 +109825,25 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17560">
+          <Source>22969141[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0225</ValMoy>
+          <PrevalenceGeographic id="24418">
+            <Name lang="de">Germany</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="2010">
@@ -113450,7 +113206,7 @@
     <Disorder id="1934">
       <OrphaCode>1997</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1997</ExpertLink>
-      <Name lang="de">Blepharo-cheilo-dentales Syndrom</Name>
+      <Name lang="de">Blepharo-cheilo-dontie-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -115838,7 +115594,7 @@
     <Disorder id="2227">
       <OrphaCode>2400</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2400</ExpertLink>
-      <Name lang="de">Periphere motorischeNeuropathie-Dysautonomie-Syndrom</Name>
+      <Name lang="de">Periphere motorische Neuropathie-Dysautonomie-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -119982,7 +119738,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="11867">
           <Source>7802035[PMID]</Source>
           <PrevalenceType id="23683">
@@ -120002,6 +119758,25 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17563">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="25293">
+            <Name lang="de">Spain</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="2061">
@@ -120772,7 +120547,7 @@
     <Disorder id="2080">
       <OrphaCode>2198</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2198</ExpertLink>
-      <Name lang="de">Palmoplantarkeratose - Ösophageales Karzinom</Name>
+      <Name lang="de">Palmoplantarkeratose-Ösophaguskarzinom-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -122419,7 +122194,7 @@
     <Disorder id="19611">
       <OrphaCode>251056</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=251056</ExpertLink>
-      <Name lang="de">Mikrodeletionssyndrom 6q25</Name>
+      <Name lang="de">Mikrodeletionssyndrom 6q25.2q25.3</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -125646,8 +125421,8 @@
         <Name lang="de">Störung</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
-        <Prevalence id="3780">
-          <Source>1068420[PMID]_8030663[PMID]</Source>
+        <Prevalence id="17477">
+          <Source>8030663[PMID]_1068420[PMID]</Source>
           <PrevalenceType id="23697">
             <Name lang="de">Cases/families</Name>
           </PrevalenceType>
@@ -125663,8 +125438,8 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="3781">
-          <Source>ORPHANET_1068420[PMID]_8030663[PMID]</Source>
+        <Prevalence id="17478">
+          <Source>8030663[PMID]_1068420[PMID]_ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="de">Punktprävalenz</Name>
           </PrevalenceType>
@@ -126111,7 +125886,7 @@
     <Disorder id="2465">
       <OrphaCode>2704</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2704</ExpertLink>
-      <Name lang="de">Ochoa-Syndrom</Name>
+      <Name lang="de">Urofaziales Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -126986,7 +126761,7 @@
         <Name lang="de">Störung</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
-        <Prevalence id="3825">
+        <Prevalence id="17481">
           <Source>[EXPERT]</Source>
           <PrevalenceType id="23697">
             <Name lang="de">Cases/families</Name>
@@ -127003,8 +126778,8 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="3826">
-          <Source>ORPHANET</Source>
+        <Prevalence id="17482">
+          <Source>[EXPERT]_ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="de">Punktprävalenz</Name>
           </PrevalenceType>
@@ -127154,55 +126929,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="2508">
-      <OrphaCode>2752</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2752</ExpertLink>
-      <Name lang="de">Oro-fazio-digitales Syndrom Typ 3</Name>
-      <DisorderType id="21401">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="3819">
-          <Source>5004413[PMID]_8230165[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="de">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="de">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>5.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="3820">
-          <Source>ORPHANET_5004413[PMID]_8230165[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="2507">
       <OrphaCode>2751</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2751</ExpertLink>
@@ -128036,7 +127762,7 @@
         <Name lang="de">Störung</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
-        <Prevalence id="3829">
+        <Prevalence id="17479">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="de">Punktprävalenz</Name>
@@ -129127,7 +128853,7 @@
     <Disorder id="19748">
       <OrphaCode>254411</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=254411</ExpertLink>
-      <Name lang="de">Annulärer atrophischer Lichen planus</Name>
+      <Name lang="de">Anulärer atrophischer Lichen planus</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -130311,7 +130037,7 @@
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=254704</ExpertLink>
       <Name lang="de">Hyperferritinämie, hereditäre, ohne Eisenüberladung</Name>
       <DisorderType id="21408">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
+        <Name lang="de">Biologische Anomalie</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
@@ -130765,7 +130491,7 @@
     <Disorder id="2309">
       <OrphaCode>2497</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2497</ExpertLink>
-      <Name lang="de">Dysplasie, mesomele, der oberen Extremität</Name>
+      <Name lang="de">Dysplasie, mesomele, der oberen Extremität, Typ Fryns</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -134840,38 +134566,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="2421">
-      <OrphaCode>2646</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2646</ExpertLink>
-      <Name lang="de">Kleinwuchs, parastrematischer</Name>
-      <DisorderType id="21401">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="3759">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="de">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="de">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="2420">
       <OrphaCode>2645</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2645</ExpertLink>
@@ -135936,7 +135630,7 @@
     <Disorder id="2725">
       <OrphaCode>3032</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=3032</ExpertLink>
-      <Name lang="de">NPHP3-assoziiertes Meckel-ähnliches Syndrom</Name>
+      <Name lang="de">Meckel-ähnliches Syndrom, NPHP3-assoziiertes</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -136067,11 +135761,11 @@
       <OrphaCode>263516</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=263516</ExpertLink>
       <Name lang="de">Myoklonische Epilepsie, progressive, Typ 3</Name>
-      <DisorderType id="21450">
-        <Name lang="de">Klinischer Subtyp</Name>
+      <DisorderType id="21394">
+        <Name lang="de">Krankheit</Name>
       </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="de">Subtyp der Störung</Name>
+      <DisorderGroup id="36547">
+        <Name lang="de">Störung</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="9327">
@@ -136690,7 +136384,7 @@
     <Disorder id="2713">
       <OrphaCode>1832</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1832</ExpertLink>
-      <Name lang="de">Knochendysplasie, osteosklerotische, letale Form</Name>
+      <Name lang="de">Knochendysplasie, osteosklerotische</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -138270,7 +137964,7 @@
     <Disorder id="2814">
       <OrphaCode>3145</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=3145</ExpertLink>
-      <Name lang="de">Nephrogener Diabetes insipidus-intrakranielle Kalzifikation-Kleinwuchs-Gesichtsdysmorphie-Syndrom</Name>
+      <Name lang="de">Arginin-Vasopressin-Resistenz-intrakranielle Kalzifikation-Kleinwuchs-Gesichtsdysmorphie-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -139769,55 +139463,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="2609">
-      <OrphaCode>2878</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2878</ExpertLink>
-      <Name lang="de">Phokomelie - Ektrodaktylie - Schwerhörigkeit - Sinusarrhythmie</Name>
-      <DisorderType id="21401">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="12754">
-          <Source>7077621[PMID]_4447434[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="de">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="de">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>4.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="12755">
-          <Source>ORPHANET_7077621[PMID]_4447434[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="20208">
       <OrphaCode>268826</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=268826</ExpertLink>
@@ -143401,7 +143046,7 @@
     <Disorder id="2660">
       <OrphaCode>2947</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2947</ExpertLink>
-      <Name lang="de">Triphalangeale Daumen - Brachyektrodaktylie</Name>
+      <Name lang="de">Triphalangeale Daumen-Brachyektrodaktylie-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -144006,7 +143651,7 @@
     <Disorder id="2648">
       <OrphaCode>2934</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2934</ExpertLink>
-      <Name lang="de">Polysyndaktylie - Herzfehler</Name>
+      <Name lang="de">Polysyndaktylie-Herzfehlbildung-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -145384,7 +145029,7 @@
     <Disorder id="2986">
       <OrphaCode>3369</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=3369</ExpertLink>
-      <Name lang="de">Trigonozephalie - Kleinwuchs - Entwicklungsverzögerung</Name>
+      <Name lang="de">Trigonozephalie-Kleinwuchs-Entwicklungsverzögerung-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -148789,7 +148434,7 @@
     <Disorder id="20315">
       <OrphaCode>275517</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=275517</ExpertLink>
-      <Name lang="de">Autoimmun-lymphoproliferatives Syndrom mit rezidivierenden Infekten</Name>
+      <Name lang="de">Autoimmun-lymphoproliferatives Syndrom mit rezidivierenden Infekten durch CASP8- Defizienz</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -149132,7 +148777,7 @@
     <Disorder id="2962">
       <OrphaCode>3339</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=3339</ExpertLink>
-      <Name lang="de">Toriello-Lacassie-Droste-Syndrom</Name>
+      <Name lang="de">Okulo-ekto-dermales Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -149182,11 +148827,11 @@
       <OrphaCode>271861</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=271861</ExpertLink>
       <Name lang="de">ATTR-Amyloidose, hereditäre</Name>
-      <DisorderType id="21436">
-        <Name lang="de">Phenom-Gruppe</Name>
+      <DisorderType id="21394">
+        <Name lang="de">Krankheit</Name>
       </DisorderType>
-      <DisorderGroup id="36540">
-        <Name lang="de">Gruppe von Störungen</Name>
+      <DisorderGroup id="36547">
+        <Name lang="de">Störung</Name>
       </DisorderGroup>
       <PrevalenceList count="41">
         <Prevalence id="17308">
@@ -153009,55 +152654,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="2865">
-      <OrphaCode>3210</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=3210</ExpertLink>
-      <Name lang="de">Summitt-Syndrom</Name>
-      <DisorderType id="21401">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="4092">
-          <Source>474616[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="de">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="de">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>3.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4093">
-          <Source>ORPHANET_474616[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="2864">
       <OrphaCode>3201</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=3201</ExpertLink>
@@ -153632,7 +153228,7 @@
     <Disorder id="2875">
       <OrphaCode>3218</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=3218</ExpertLink>
-      <Name lang="de">Schwerhörigkeit - epiphysäre Dysplasie - Kleinwuchs</Name>
+      <Name lang="de">Schwerhörigkeit-epiphysäre Dysplasie-Kleinwuchs-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -154858,7 +154454,7 @@
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=280183</ExpertLink>
       <Name lang="de">Methylmalonazidurie durch Transcobalamin-Rezeptor-Defekt</Name>
       <DisorderType id="21408">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
+        <Name lang="de">Biologische Anomalie</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
@@ -155372,7 +154968,7 @@
     <Disorder id="2916">
       <OrphaCode>3265</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=3265</ExpertLink>
-      <Name lang="de">Synostose, humero-radiale</Name>
+      <Name lang="de">Synostose, humero-radiale isolierte</Name>
       <DisorderType id="21415">
         <Name lang="de">Morphologische Anomalie</Name>
       </DisorderType>
@@ -155453,7 +155049,7 @@
     <Disorder id="2917">
       <OrphaCode>3266</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=3266</ExpertLink>
-      <Name lang="de">Synostose, humero-radio-ulnare</Name>
+      <Name lang="de">Synostose, humero-radio-ulnare isolierte</Name>
       <DisorderType id="21415">
         <Name lang="de">Morphologische Anomalie</Name>
       </DisorderType>
@@ -156409,55 +156005,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="2883">
-      <OrphaCode>3226</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=3226</ExpertLink>
-      <Name lang="de">Taubheit-Lymphödem-Leukämie-Syndrom</Name>
-      <DisorderType id="21401">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="4104">
-          <Source>ORPHANET_21892158[PMID]_20803646[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="de">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="de">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>20.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4105">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="20353">
       <OrphaCode>276183</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=276183</ExpertLink>
@@ -157484,7 +157031,7 @@
     <Disorder id="2905">
       <OrphaCode>3248</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=3248</ExpertLink>
-      <Name lang="de">Symphalangismus, distaler</Name>
+      <Name lang="de">Symphalangismus, isolierter distaler</Name>
       <DisorderType id="21415">
         <Name lang="de">Morphologische Anomalie</Name>
       </DisorderType>
@@ -158886,7 +158433,7 @@
     <Disorder id="3297">
       <OrphaCode>6</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=6</ExpertLink>
-      <Name lang="de">3-Methylcrotonyl-CoA-Carboxylase-Mangel, isolierter</Name>
+      <Name lang="de">3-Methylcrotonyl-CoA-Carboxylase-Mangel</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -159967,7 +159514,7 @@
     <Disorder id="3214">
       <OrphaCode>1655</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1655</ExpertLink>
-      <Name lang="de">Müller-Gang-Derivate - Lymphangiektasie - Polydaktylie</Name>
+      <Name lang="de">Müller-Gang-Derivate-Lymphangiektasie-Polydaktylie-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -160627,7 +160174,7 @@
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=206599</ExpertLink>
       <Name lang="de">Erhöhung der Kreatinphosphokinase, isolierte asymptomatische Form</Name>
       <DisorderType id="21408">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
+        <Name lang="de">Biologische Anomalie</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
@@ -160771,55 +160318,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="3238">
-      <OrphaCode>2729</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2729</ExpertLink>
-      <Name lang="de">Okamoto-Syndrom</Name>
-      <DisorderType id="21401">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="4346">
-          <Source>20179579[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="de">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="de">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>5.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4347">
-          <Source>ORPHANET_20179579[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="3243">
       <OrphaCode>65</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=65</ExpertLink>
@@ -161379,38 +160877,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="3165">
-      <OrphaCode>2756</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2756</ExpertLink>
-      <Name lang="de">Oro-fazio-digitales Syndrom Typ 10</Name>
-      <DisorderType id="21401">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="4307">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="de">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="de">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="3167">
       <OrphaCode>2326</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2326</ExpertLink>
@@ -161708,7 +161174,7 @@
     <Disorder id="3148">
       <OrphaCode>2062</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2062</ExpertLink>
-      <Name lang="de">Wirbelfusion, progrediente, nicht-infektiöse syndromale Form</Name>
+      <Name lang="de">Progrediente nicht-infektiöse anteriore Wirbelfusion</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -161716,7 +161182,7 @@
         <Name lang="de">Störung</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
-        <Prevalence id="4295">
+        <Prevalence id="17495">
           <Source>25485486[PMID]_28235247[PMID]</Source>
           <PrevalenceType id="23697">
             <Name lang="de">Cases/families</Name>
@@ -161733,8 +161199,8 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="4296">
-          <Source>ORPHANET_25485486[PMID]_28235247[PMID]</Source>
+        <Prevalence id="17496">
+          <Source>25485486[PMID]_28235247[PMID]_ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="de">Punktprävalenz</Name>
           </PrevalenceType>
@@ -161806,7 +161272,7 @@
     <Disorder id="3150">
       <OrphaCode>2427</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2427</ExpertLink>
-      <Name lang="de">Makrozephalie - Kleinwuchs - Paraplegie</Name>
+      <Name lang="de">Makrozephalie-Kleinwuchs-Paraplegie-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -162804,55 +162270,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="3103">
-      <OrphaCode>2653</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2653</ExpertLink>
-      <Name lang="de">Kleinwuchs, osteochondrodysplastischer - Schwerhörigkeit - Retinitis pigmentosa</Name>
-      <DisorderType id="21401">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="4272">
-          <Source>2783003[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="de">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="de">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>2.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4273">
-          <Source>ORPHANET_2783003[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="18654">
       <OrphaCode>209335</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=209335</ExpertLink>
@@ -164098,7 +163515,7 @@
     <Disorder id="3114">
       <OrphaCode>2795</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2795</ExpertLink>
-      <Name lang="de">Polyzystische Ovarien - Dysfunktion des Urethra-Sphinkters</Name>
+      <Name lang="de">Fowler-Syndrom der Dysfunktion des urethralen Sphinkters</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -165157,7 +164574,7 @@
     <Disorder id="18698">
       <OrphaCode>210584</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=210584</ExpertLink>
-      <Name lang="de">Spindelzellhämangiom</Name>
+      <Name lang="de">Spindelzell-Hämangiom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -165887,7 +165304,7 @@
     <Disorder id="3543">
       <OrphaCode>1063</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1063</ExpertLink>
-      <Name lang="de">Angiom, büschelartiges</Name>
+      <Name lang="de">Hämangiom, büschelartiges</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -173194,7 +172611,7 @@
     <Disorder id="3489">
       <OrphaCode>3269</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=3269</ExpertLink>
-      <Name lang="de">Radio-ulnare Synostose, kongenitale</Name>
+      <Name lang="de">Radio-ulnare Synostose, isolierte kongenitale</Name>
       <DisorderType id="21415">
         <Name lang="de">Morphologische Anomalie</Name>
       </DisorderType>
@@ -173759,10 +173176,42 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="18790">
+      <OrphaCode>216729</OrphaCode>
+      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=216729</ExpertLink>
+      <Name lang="de">Kongenitale unkorrigierte Transposition der großen Arterien mit Herzfehlbildung</Name>
+      <DisorderType id="21450">
+        <Name lang="de">Klinischer Subtyp</Name>
+      </DisorderType>
+      <DisorderGroup id="36554">
+        <Name lang="de">Subtyp der Störung</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="8746">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25965">
+            <Name lang="de">Not yet validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="3495">
       <OrphaCode>3411</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=3411</ExpertLink>
-      <Name lang="de">Uterusverdoppelung - Hemivagina - Nierenagenesie</Name>
+      <Name lang="de">Uterusverdoppelung-Hemivagina-Nierenagenesie-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -173808,38 +173257,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="18790">
-      <OrphaCode>216729</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=216729</ExpertLink>
-      <Name lang="de">Kongenitale unkorrigierte Transposition der großen Arterien mit Herzfehlbildung</Name>
-      <DisorderType id="21450">
-        <Name lang="de">Klinischer Subtyp</Name>
-      </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="de">Subtyp der Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="8746">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="de">Unbekannt</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="de">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="3494">
       <OrphaCode>882</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=882</ExpertLink>
@@ -175822,7 +175239,7 @@
     <Disorder id="18818">
       <OrphaCode>217059</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=217059</ExpertLink>
-      <Name lang="de">Trommelschlägelfinger, isolierte kongenitale</Name>
+      <Name lang="de">Trommelschlägelfinger, isolierte</Name>
       <DisorderType id="21415">
         <Name lang="de">Morphologische Anomalie</Name>
       </DisorderType>
@@ -176305,38 +175722,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="3413">
-      <OrphaCode>344</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=344</ExpertLink>
-      <Name lang="de">Arbovirus-Fieber</Name>
-      <DisorderType id="36561">
-        <Name lang="de">Kategorie</Name>
-      </DisorderType>
-      <DisorderGroup id="36540">
-        <Name lang="de">Gruppe von Störungen</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="4535">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="de">Unbekannt</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="de">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="3412">
       <OrphaCode>341</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=341</ExpertLink>
@@ -177042,12 +176427,12 @@
     <Disorder id="3434">
       <OrphaCode>1456</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1456</ExpertLink>
-      <Name lang="de">Aortenisthmusstenose, atypische</Name>
-      <DisorderType id="21450">
-        <Name lang="de">Klinischer Subtyp</Name>
+      <Name lang="de">Mid-Aortic-Syndrom</Name>
+      <DisorderType id="21415">
+        <Name lang="de">Morphologische Anomalie</Name>
       </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="de">Subtyp der Störung</Name>
+      <DisorderGroup id="36547">
+        <Name lang="de">Störung</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="4551">
@@ -179446,7 +178831,26 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17551">
+          <Source>17570073[PMID]_21123949[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23851">
+            <Name lang="de">Spezifische Population</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="12575">
           <Source>17570073[PMID]_21123949[PMID]</Source>
           <PrevalenceType id="23683">
@@ -180291,7 +179695,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="4">
+      <PrevalenceList count="5">
         <Prevalence id="4500">
           <Source>19650784[PMID]</Source>
           <PrevalenceType id="23669">
@@ -180368,6 +179772,25 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17513">
+          <Source>16968795[PMID]_ 19650784[PMID]_ 19968031[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="de">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>50.7</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="de">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="18939">
@@ -181921,7 +181344,7 @@
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=228000</ExpertLink>
       <Name lang="de">CD4-Lymphozytopenie, idiopathische</Name>
       <DisorderType id="21408">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
+        <Name lang="de">Biologische Anomalie</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
@@ -184652,7 +184075,7 @@
     <Disorder id="3737">
       <OrphaCode>3148</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=3148</ExpertLink>
-      <Name lang="de">Schwannom, malignes</Name>
+      <Name lang="de">Nervenscheidentumor, maligner peripherer</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -185785,7 +185208,7 @@
     <Disorder id="3726">
       <OrphaCode>223</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=223</ExpertLink>
-      <Name lang="de">Diabetes insipidus, nephrogener</Name>
+      <Name lang="de">Arginin-Vasopressin-Resistenz</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -185885,7 +185308,7 @@
     <Disorder id="19131">
       <OrphaCode>228423</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=228423</ExpertLink>
-      <Name lang="de">Monozytopenie mit erhöhter Infektionsanfälligkeit</Name>
+      <Name lang="de">GATA2-Defizienz-Spektrum</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -186091,7 +185514,7 @@
     <Disorder id="3704">
       <OrphaCode>132</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=132</ExpertLink>
-      <Name lang="de">Butyrylcholinesterase-Mangel</Name>
+      <Name lang="de">Butyrylcholinesterase-Mangel, hereditärer</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -186493,7 +185916,7 @@
     <Disorder id="19121">
       <OrphaCode>228390</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=228390</ExpertLink>
-      <Name lang="de">Fronto-nasale Dysplasie mit Alopezie und Genitalanomalien</Name>
+      <Name lang="de">Frontonasale Dysplasie-Alopezie-Genitalanomalien-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -186542,7 +185965,7 @@
     <Disorder id="19127">
       <OrphaCode>228410</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=228410</ExpertLink>
-      <Name lang="de">Syndrom der polyvalvulären Herzfehlbildung</Name>
+      <Name lang="de">Herzanomalien-Kleinwuchs-Gelenkhypermobilität-Gesichtsdysmorphien-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -186741,11 +186164,11 @@
       <OrphaCode>228384</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=228384</ExpertLink>
       <Name lang="de">Mikrodeletionssyndrom 5q14.3</Name>
-      <DisorderType id="21401">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
+      <DisorderType id="21443">
+        <Name lang="de">Ätiologischer Subtyp</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
+      <DisorderGroup id="36554">
+        <Name lang="de">Subtyp der Störung</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="8912">
@@ -189193,7 +188616,7 @@
     <Disorder id="19177">
       <OrphaCode>231249</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=231249</ExpertLink>
-      <Name lang="de">Hämoglobin E - Beta-Thalassämie</Name>
+      <Name lang="de">Hämoglobin E-Beta-Thalassämie-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -189576,7 +188999,7 @@
     <Disorder id="3619">
       <OrphaCode>2841</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=2841</ExpertLink>
-      <Name lang="de">Pemphigus, benigner chronischer familiärer</Name>
+      <Name lang="de">Hailey-Hailey-Krankheit</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -193210,7 +192633,7 @@
     <Disorder id="19332">
       <OrphaCode>240085</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=240085</ExpertLink>
-      <Name lang="de">Progressive supranukleäre Blickparese - Parkinsonismus</Name>
+      <Name lang="de">Progressive supranukleäre Blickparese-predominanter Parkinsonismus-Syndrom</Name>
       <DisorderType id="21450">
         <Name lang="de">Klinischer Subtyp</Name>
       </DisorderType>
@@ -193372,7 +192795,7 @@
     <Disorder id="21992">
       <OrphaCode>331176</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=331176</ExpertLink>
-      <Name lang="de">Neutropenie, kongenitale schwere, autosomal-rezessive, durch G6PC3-Mangel</Name>
+      <Name lang="de">Neutropenie, kongenitale schwere, durch G6PC3-Mangel</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -194955,7 +194378,7 @@
     <Disorder id="21935">
       <OrphaCode>329469</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=329469</ExpertLink>
-      <Name lang="de">Akute Megakaryoblastenleukämie ohne Down-Syndrom</Name>
+      <Name lang="de">Akute megakaryoblastische Leukämie bei Kindern ohne Down-Syndrom</Name>
       <DisorderType id="21450">
         <Name lang="de">Klinischer Subtyp</Name>
       </DisorderType>
@@ -200687,7 +200110,7 @@
     <Disorder id="21585">
       <OrphaCode>317476</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=317476</ExpertLink>
-      <Name lang="de">Immundefekt, X-chromosomaler, mit Magnesium-Defekt, Epstein-Barr-Virus-Infektion und Neoplasie</Name>
+      <Name lang="de">XMEN</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -204233,7 +203656,7 @@
     <Disorder id="22437">
       <OrphaCode>369852</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=369852</ExpertLink>
-      <Name lang="de">Rezidivierende Infekte-Myelofibrose-Nephromegalie-Syndrom</Name>
+      <Name lang="de">Kongenitale Neutropenie-Myelofibrose-Nephromegalie-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -208649,7 +208072,7 @@
     <Disorder id="22219">
       <OrphaCode>357237</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=357237</ExpertLink>
-      <Name lang="de">Immundefekt, kombinierter schwerer, durch CARD11-Mangel</Name>
+      <Name lang="de">Immundefekt, kombinierter, durch CARD11-Mangel</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -211168,7 +210591,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="9799">
           <Source>18589446[PMID]</Source>
           <PrevalenceType id="23683">
@@ -211188,6 +210611,25 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17566">
+          <Source>36215864[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="de">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>42.4691</ValMoy>
+          <PrevalenceGeographic id="24607">
+            <Name lang="de">Italy</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="20900">
@@ -212220,7 +211662,7 @@
     <Disorder id="20937">
       <OrphaCode>294975</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=294975</ExpertLink>
-      <Name lang="de">Angeborenes Fehlen des Ober- und Unterarms mit vorhandener Hand</Name>
+      <Name lang="de">Isoliertes Fehlen von Ober- und Unterarm bei vorhandener Hand</Name>
       <DisorderType id="21415">
         <Name lang="de">Morphologische Anomalie</Name>
       </DisorderType>
@@ -212303,7 +211745,7 @@
     <Disorder id="20935">
       <OrphaCode>294971</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=294971</ExpertLink>
-      <Name lang="de">Tetraamelie</Name>
+      <Name lang="de">Tetraamelie, isolierte</Name>
       <DisorderType id="21415">
         <Name lang="de">Morphologische Anomalie</Name>
       </DisorderType>
@@ -212448,7 +211890,7 @@
     <Disorder id="20756">
       <OrphaCode>289661</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=289661</ExpertLink>
-      <Name lang="de">Epstein-Barr Virus-positive diffuse großzellige B-Zell-Lymphom des älteren Erwachsenen</Name>
+      <Name lang="de">Epstein-Barr Virus-positives diffuses großzelliges B-Zell-Lymphom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -217638,7 +217080,7 @@
     <Disorder id="20592">
       <OrphaCode>284282</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=284282</ExpertLink>
-      <Name lang="de">Autosomal-rezessive zerebelläre Ataxie - Epilepsie - Intelligenzminderung</Name>
+      <Name lang="de">Autosomal-rezessive zerebelläre Ataxie-Epilepsie-Intelligenzminderung-Syndrom durch WWOX-Mangel</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -223499,7 +222941,7 @@
     <Disorder id="21222">
       <OrphaCode>306516</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=306516</ExpertLink>
-      <Name lang="de">Familiäre primäre Hypomagnesiämie mit Hyperkalziurie und Nephrokalzinose</Name>
+      <Name lang="de">Primäre Hypomagnesiämie mit Hyperkalziurie und Nephrokalzinose</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -223710,7 +223152,7 @@
     <Disorder id="21236">
       <OrphaCode>306577</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=306577</ExpertLink>
-      <Name lang="de">Natrium-Ionenkanalkrankheit-assoziierte Small-Fiber-Neuropathie</Name>
+      <Name lang="de">Hereditäre Natrium-Ionenkanalkrankheit-assoziierte Small-Fiber-Neuropathie</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -225180,7 +224622,7 @@
     <Disorder id="24048">
       <OrphaCode>464756</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=464756</ExpertLink>
-      <Name lang="de">Familiärer Neuroendokriner Tumor des Magens Typ 1</Name>
+      <Name lang="de">Familiärer neuroendokriner Magentumor Typ 1</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -226437,7 +225879,7 @@
     <Disorder id="23658">
       <OrphaCode>454723</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=454723</ExpertLink>
-      <Name lang="de">Endometriumskarzinom des Ovars</Name>
+      <Name lang="de">Endometrioides Ovarialkarzinom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -226610,7 +226052,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="4">
         <Prevalence id="12112">
           <Source>25976171[PMID]</Source>
           <PrevalenceType id="23683">
@@ -226649,6 +226091,44 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17524">
+          <Source>22945024[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="de">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>2.2</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17543">
+          <Source>25976171[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="de">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>4.2</ValMoy>
+          <PrevalenceGeographic id="23949">
+            <Name lang="de">Australia</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="23660">
@@ -227012,7 +226492,7 @@
     <Disorder id="23645">
       <OrphaCode>453499</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=453499</ExpertLink>
-      <Name lang="de">Neurologische Entwicklungsstörungen-kranio-faziale Dysmorphie-Herzfehler-Skelettanomalien-Syndrom</Name>
+      <Name lang="de">Neurologische Entwicklungsstörungen-kranio-faziale Dysmorphie-Herzfehler-Skelettanomalie-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -228531,7 +228011,7 @@
     <Disorder id="23749">
       <OrphaCode>458718</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=458718</ExpertLink>
-      <Name lang="de">Idiopathische spontane Koronararteriendissektion</Name>
+      <Name lang="de">Spontane Koronararteriendissektion</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -228661,7 +228141,7 @@
     <Disorder id="23752">
       <OrphaCode>458768</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=458768</ExpertLink>
-      <Name lang="de">Primär intralymphatisches Angioendotheliom</Name>
+      <Name lang="de">Papilläres intralymphatisches Angioendotheliom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -229298,7 +228778,7 @@
     <Disorder id="23723">
       <OrphaCode>457365</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=457365</ExpertLink>
-      <Name lang="de">Intelligenzminderung--Muskelschwäche-Kleinwuchs-Gesichtsdysmorphie-Syndrom</Name>
+      <Name lang="de">Intelligenzminderung-Muskelschwäche-Kleinwuchs-Gesichtsdysmorphie-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -230484,7 +229964,7 @@
     <Disorder id="7030">
       <OrphaCode>1303</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=1303</ExpertLink>
-      <Name lang="de">Bronchiolitis obliterans mit obstruktiver Lungenerkrankung</Name>
+      <Name lang="de">Bronchiolitis obliterans</Name>
       <DisorderType id="21436">
         <Name lang="de">Phenom-Gruppe</Name>
       </DisorderType>
@@ -235310,7 +234790,7 @@
     <Disorder id="22938">
       <OrphaCode>404553</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=404553</ExpertLink>
-      <Name lang="de">Vaskulitis durch ADA2-Mangel</Name>
+      <Name lang="de">Adenosin-Desaminase 2-Mangel</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -236805,7 +236285,7 @@
     <Disorder id="22628">
       <OrphaCode>391487</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=391487</ExpertLink>
-      <Name lang="de">Autoimmune Enteropathie und Endokrinopathie-Empfänglichkeit für chronische Infektionen-Syndrom</Name>
+      <Name lang="de">STAT1-assoziierte autoimmune Enteropathie und Endokrinopathie-Empfänglichkeit für chronische Infektionen-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -242274,7 +241754,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="11292">
           <Source>9061661[PMID]</Source>
           <PrevalenceType id="23683">
@@ -242294,6 +241774,25 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17567">
+          <Source>30252317[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="de">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>5.0</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="de">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="22729">
@@ -243564,7 +243063,7 @@
     <Disorder id="23326">
       <OrphaCode>436141</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=436141</ExpertLink>
-      <Name lang="de">Schwere Intelligenzminderung-Hypotonie-Strabismus-grobe Gesichtsszüge-Planovalgus-Syndrom</Name>
+      <Name lang="de">HIDEA-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -243613,7 +243112,7 @@
     <Disorder id="23327">
       <OrphaCode>436144</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=436144</ExpertLink>
-      <Name lang="de">Intrauterine Wachstumsretardierung-Kleinwuchs-im frühen Erwachsenenalter beginnender Diabetes-Syndrom</Name>
+      <Name lang="de">Intrauterine Wachstumsretardierung-Kleinwuchs-früh-adulter Diabetes-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -245392,7 +244891,7 @@
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=440731</ExpertLink>
       <Name lang="de">L-Ferritin-Mangel</Name>
       <DisorderType id="21408">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
+        <Name lang="de">Biologische Anomalie</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
@@ -247108,7 +246607,7 @@
     <Disorder id="23490">
       <OrphaCode>444463</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=444463</ExpertLink>
-      <Name lang="de">Evans-Syndrom mit assoziiertem primären Immundefekt</Name>
+      <Name lang="de">Syndrom der autoimmunen hämolytischen Anämie mit autoimmuner Thrombozytopenie und primärem Immundefekt</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -247355,7 +246854,7 @@
     <Disorder id="23516">
       <OrphaCode>445038</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=445038</ExpertLink>
-      <Name lang="de">3-Methylglutaconazidurie Typ 7</Name>
+      <Name lang="de">3-Methylglutaconazidurie-Katarakt-neurologische Beteiligung-Neutropenie-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -247502,7 +247001,7 @@
     <Disorder id="23534">
       <OrphaCode>447737</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=447737</ExpertLink>
-      <Name lang="de">DOCK2-Mangel</Name>
+      <Name lang="de">Kombinierter Immundefekt durch DOCK2-Mangel</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -247715,7 +247214,7 @@
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=447795</ExpertLink>
       <Name lang="de">Lipoyl-Transferase 2-Mangel</Name>
       <DisorderType id="21408">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
+        <Name lang="de">Biologische Anomalie</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
@@ -248088,7 +247587,7 @@
     <Disorder id="23042">
       <OrphaCode>412069</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=412069</ExpertLink>
-      <Name lang="de">Intelligenzminderung-obstruktive Schlafapnoe-milde Dysmorphien-Syndrom durch AHDC1-Genmutation</Name>
+      <Name lang="de">Xia-Gibbs-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -250461,7 +249960,7 @@
     <Disorder id="23154">
       <OrphaCode>423384</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=423384</ExpertLink>
-      <Name lang="de">Neutropenie, kongenitale schwere, autosomal-rezessive, durch JAGN1-Mangel</Name>
+      <Name lang="de">Neutropenie, kongenitale schwere, durch JAGN1-Mangel</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -250608,7 +250107,7 @@
     <Disorder id="23160">
       <OrphaCode>423479</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=423479</ExpertLink>
-      <Name lang="de">X-chromosomale Intelligenzminderung-Spastizität der Extremitäten-Netzhautdystrophie-Diabetes insipidus-Syndrom</Name>
+      <Name lang="de">X-chromosomale Intelligenzminderung-Spastizität der Extremitäten-Netzhautdystrophie-Arginin-Vasopressin-Mangel-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -258844,7 +258343,7 @@
     <Disorder id="8781">
       <OrphaCode>30391</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=30391</ExpertLink>
-      <Name lang="de">Gallengangatresie</Name>
+      <Name lang="de">Gallengangatresie, isolierte</Name>
       <DisorderType id="21415">
         <Name lang="de">Morphologische Anomalie</Name>
       </DisorderType>
@@ -259495,7 +258994,7 @@
     <Disorder id="8748">
       <OrphaCode>162</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=162</ExpertLink>
-      <Name lang="de">Katarakt-Glaukom-Syndrom</Name>
+      <Name lang="de">Syndrom der kongenitalen Katarakt mit Dysgenesie des vorderen Augensegmentes</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -265264,7 +264763,7 @@
     <Disorder id="8531">
       <OrphaCode>302</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=302</ExpertLink>
-      <Name lang="de">Epidermodysplasia verruciformis</Name>
+      <Name lang="de">Epidermodysplasia verruciformis, hereditäre</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -266749,7 +266248,7 @@
     <Disorder id="8545">
       <OrphaCode>400</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=400</ExpertLink>
-      <Name lang="de">Hydatidose</Name>
+      <Name lang="de">Zystische Echinokokkose</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -267327,7 +266826,7 @@
     <Disorder id="26077">
       <OrphaCode>502430</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=502430</ExpertLink>
-      <Name lang="de">Metopicaleiste-Ptosis-Gesichtsdysmorphie-Syndrom</Name>
+      <Name lang="de">Weiss-Kruszka-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -268994,7 +268493,7 @@
     <Disorder id="8685">
       <OrphaCode>877</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=877</ExpertLink>
-      <Name lang="de">Tumor, neuroendokriner</Name>
+      <Name lang="de">Neuroendokrine Neoplasie</Name>
       <DisorderType id="36561">
         <Name lang="de">Kategorie</Name>
       </DisorderType>
@@ -270120,7 +269619,45 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="15">
+      <PrevalenceList count="17">
+        <Prevalence id="17525">
+          <Source>European Centre for Disease prevention and Control 2013-2017[INST]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="de">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.3</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="de">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17527">
+          <Source>CDC Centers for disease Control and prevention 2016[INST]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="de">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>15.7</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="de">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="13948">
           <Source>CDC Centers for disease Control and prevention 2016[INST]</Source>
           <PrevalenceType id="23683">
@@ -272106,7 +271643,7 @@
     <Disorder id="8611">
       <OrphaCode>81</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=81</ExpertLink>
-      <Name lang="de">Antisynthetase-Syndrom</Name>
+      <Name lang="de">Anti-Synthetase-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -275222,7 +274759,7 @@
     <Disorder id="25413">
       <OrphaCode>488647</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=488647</ExpertLink>
-      <Name lang="de">Hämatologische Malignität-Prädispositionssyndrom, DDX41-assoziiertes</Name>
+      <Name lang="de">Tumorprädispositionssyndrom, DDX41-assoziiertes</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -276055,7 +275592,7 @@
     <Disorder id="25364">
       <OrphaCode>487796</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=487796</ExpertLink>
-      <Name lang="de">Makrothrombozytopenie-Lymphödem-Entwicklungsverzögerung-Gesichtsdysmorphien-Kamptodaktylie-Syndrom</Name>
+      <Name lang="de">Takenouchi-Kosaki-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -276153,7 +275690,7 @@
     <Disorder id="25368">
       <OrphaCode>487809</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=487809</ExpertLink>
-      <Name lang="de">Gastritis, kollagene, des Kindes</Name>
+      <Name lang="de">Gastritis, kollagene, pädiatrische</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -276564,7 +276101,7 @@
     <Disorder id="9283">
       <OrphaCode>30925</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=30925</ExpertLink>
-      <Name lang="de">Diabetes insipidus, zentraler, hereditärer</Name>
+      <Name lang="de">Hereditärer Arginin-Vasopressin-Mangel</Name>
       <DisorderType id="21450">
         <Name lang="de">Klinischer Subtyp</Name>
       </DisorderType>
@@ -276691,55 +276228,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="25087">
-      <OrphaCode>476102</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=476102</ExpertLink>
-      <Name lang="de">Behçet-ähnliche Krankheit des Kindes, hereditäre</Name>
-      <DisorderType id="21394">
-        <Name lang="de">Krankheit</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="13099">
-          <Source>26642243[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="de">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="de">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>13.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="13100">
-          <Source>ORPHANET_26642243[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="25085">
       <OrphaCode>476093</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=476093</ExpertLink>
@@ -277084,7 +276572,7 @@
     <Disorder id="10998">
       <OrphaCode>71276</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=71276</ExpertLink>
-      <Name lang="de">Silent Sinus-Syndrom</Name>
+      <Name lang="de">Silent-sinus-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -281291,7 +280779,7 @@
     <Disorder id="10893">
       <OrphaCode>66637</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=66637</ExpertLink>
-      <Name lang="de">Diaphano-spondylo-Dysostose</Name>
+      <Name lang="de">Diaphanospondylodysostose</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -281372,7 +280860,7 @@
     <Disorder id="10891">
       <OrphaCode>66633</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=66633</ExpertLink>
-      <Name lang="de">Sensorineurale Schwerhörigkeit - frühes Ergrauen - essentieller Tremor</Name>
+      <Name lang="de">Sensorineurale Schwerhörigkeit-frühes Ergrauen-essentieller Tremor-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -281827,55 +281315,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="10880">
-      <OrphaCode>65798</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=65798</ExpertLink>
-      <Name lang="de">Goodman-Syndrom</Name>
-      <DisorderType id="21401">
-        <Name lang="de">Fehlbildungs-Syndrom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="5925">
-          <Source>421359[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="de">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="de">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>3.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="5926">
-          <Source>ORPHANET_421359[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="10865">
       <OrphaCode>65283</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=65283</ExpertLink>
@@ -284120,7 +283559,7 @@
     <Disorder id="10804">
       <OrphaCode>60039</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=60039</ExpertLink>
-      <Name lang="de">Pudendusneuralgie</Name>
+      <Name lang="de">Pudendus-Nervenkompression</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -287003,7 +286442,7 @@
     <Disorder id="28477">
       <OrphaCode>566067</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=566067</ExpertLink>
-      <Name lang="de">CEBPE-assoziierte Autoinflammation-Immundefekt- neutrophile Funktionsstörung-Syndrom</Name>
+      <Name lang="de">CEBPE-assoziierte Autoinflammation-Immundefekt-neutrophile Funktionsstörung-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -288203,7 +287642,45 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="4">
+        <Prevalence id="17546">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="de">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17547">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="24621">
+            <Name lang="de">Japan</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="15429">
           <Source>14517508[PMID]_31149222[PMID]</Source>
           <PrevalenceType id="23683">
@@ -288247,7 +287724,7 @@
     <Disorder id="11151">
       <OrphaCode>79118</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=79118</ExpertLink>
-      <Name lang="de">Neugeborenen-Diabetes - kongenitale Hypothyreose - kongenitales Glaukom - Leberfibrose - polyzystische Nieren</Name>
+      <Name lang="de">Neonataler Diabetes-kongenitale Hypothyreose-kongenitales Glaukom-Leberfibrose-polyzystische Nieren-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -290041,7 +289518,7 @@
     <Disorder id="11112">
       <OrphaCode>77300</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=77300</ExpertLink>
-      <Name lang="de">Ohrenanomalien - Lippen-Kiefer-Gaumenspalte - Augenanomalien</Name>
+      <Name lang="de">Ohranomalien-Lippenspalte mit oder ohne Gaumenspalte-Augenanomalien-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -290680,7 +290157,7 @@
     <Disorder id="11134">
       <OrphaCode>79091</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=79091</ExpertLink>
-      <Name lang="de">Hereditäre Einschlusskörperchenmyopathie - Gelenkkontrakturen - Ophthalmoplegie</Name>
+      <Name lang="de">Hereditäre Einschlusskörperchenmyopathie-Gelenkkontrakturen-Ophthalmoplegie-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -291138,7 +290615,7 @@
     <Disorder id="11080">
       <OrphaCode>75389</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=75389</ExpertLink>
-      <Name lang="de">Hirnfehlbildungen - kongenitaler Herzfehler - postaxiale Polydaktylie</Name>
+      <Name lang="de">Hirnfehlbildung-kongenitaler Herzfehler-postaxiale Polydaktylie-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -292442,7 +291919,7 @@
     <Disorder id="11071">
       <OrphaCode>75326</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=75326</ExpertLink>
-      <Name lang="de">Tortuositas der retinalen Arterien</Name>
+      <Name lang="de">Familiäre isolierte Tortuosität der Netzhautarterien</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -292491,7 +291968,7 @@
     <Disorder id="11070">
       <OrphaCode>75325</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=75325</ExpertLink>
-      <Name lang="de">Osteosklerose - Ichthyose - vorzeitige Ovarialinsuffizienz</Name>
+      <Name lang="de">Osteosklerose-Ichthyose-vorzeitige Ovarialinsuffizienz-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -292693,7 +292170,7 @@
     <Disorder id="28613">
       <OrphaCode>568065</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=568065</ExpertLink>
-      <Name lang="de">EPHB4-assoziierter fetaler Hydrops mit generalisierter lymphatischer Dysplasie</Name>
+      <Name lang="de">EPHB4-assoziierter lymphatisch bedingter Hydrops fetalis</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -292742,7 +292219,7 @@
     <Disorder id="28612">
       <OrphaCode>568062</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=568062</ExpertLink>
-      <Name lang="de">PIEZO1-assoziierter fetaler Hydrops mit generalisierter lymphatischer Dysplasie</Name>
+      <Name lang="de">PIEZO1-assoziierte generalisierte lymphatische Dysplasie mit nicht-immunem Hydrops fetalis</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -292936,7 +292413,7 @@
     <Disorder id="11011">
       <OrphaCode>71289</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=71289</ExpertLink>
-      <Name lang="de">Radioulnar-Synostose - amegakaryozytische Thrombozytopenie</Name>
+      <Name lang="de">Radioulnare Synostose-amegakaryozytische Thrombozytopenie-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -293475,7 +292952,7 @@
     <Disorder id="11036">
       <OrphaCode>73224</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=73224</ExpertLink>
-      <Name lang="de">Syndrom der Nierentubulopathie mit dilatierter Kardiomyopathie</Name>
+      <Name lang="de">Nierentubulopathie-dilatative Kardiomyopathie-Syndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -293524,7 +293001,7 @@
     <Disorder id="11039">
       <OrphaCode>73245</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=73245</ExpertLink>
-      <Name lang="de">Spinale Muskelatrophie - Dandy-Walker-Malformation - Katarakte</Name>
+      <Name lang="de">Spinale Muskelatrophie-Dandy-Walker-Fehlbildung-Katarakt-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -295974,7 +295451,7 @@
     <Disorder id="10415">
       <OrphaCode>36273</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=36273</ExpertLink>
-      <Name lang="de">Linitis plastica</Name>
+      <Name lang="de">Gastrische Linitis plastica</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -297148,7 +296625,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="3">
+      <PrevalenceList count="4">
         <Prevalence id="5542">
           <Source>Pr Ralph GRÄSBECK[EXPERT]</Source>
           <PrevalenceType id="23669">
@@ -297206,6 +296683,25 @@
             <Name lang="de">Not yet validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17514">
+          <Source>Pr Ralph GRÄSBECK[EXPERT]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="de">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.5</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="de">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="10405">
@@ -297744,6 +297240,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="10333">
+      <OrphaCode>34217</OrphaCode>
+      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=34217</ExpertLink>
+      <Name lang="de">Naxos-Krankheit</Name>
+      <DisorderType id="21394">
+        <Name lang="de">Krankheit</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="de">Störung</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17476">
+          <Source>15210133[PMID]_34926342[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="10330">
       <OrphaCode>33577</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=33577</ExpertLink>
@@ -298124,7 +297652,7 @@
     <Disorder id="10305">
       <OrphaCode>33001</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=33001</ExpertLink>
-      <Name lang="de">Lymphödem - Distichiasis</Name>
+      <Name lang="de">Lymphödem-Distichiasis-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -299116,7 +298644,26 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17552">
+          <Source>34626670[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="de">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>20.7</ValMoy>
+          <PrevalenceGeographic id="23949">
+            <Name lang="de">Australia</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="17059">
           <Source>34626670[PMID]</Source>
           <PrevalenceType id="23683">
@@ -299405,7 +298952,7 @@
     <Disorder id="10348">
       <OrphaCode>34587</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=34587</ExpertLink>
-      <Name lang="de">Glykogenose durch LAMP-2-Mangel</Name>
+      <Name lang="de">Glykogenose Typ IIb</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -301595,7 +301142,7 @@
     <Disorder id="10749">
       <OrphaCode>54251</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=54251</ExpertLink>
-      <Name lang="de">Kortikosteroidsensitives aseptisches Abszesssyndrom</Name>
+      <Name lang="de">Aseptisches Abszesssyndrom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -301644,7 +301191,7 @@
     <Disorder id="27963">
       <OrphaCode>538931</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=538931</ExpertLink>
-      <Name lang="de">X-chromosomales lymphoproliferatives Syndrom durch SH2D1A-Mangel</Name>
+      <Name lang="de">X-chromosomales lymphoproliferatives Syndrom durch SAP-Mangel</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -302689,7 +302236,7 @@
     <Disorder id="10630">
       <OrphaCode>48652</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=48652</ExpertLink>
-      <Name lang="de">Monosomie 22q13</Name>
+      <Name lang="de">Phelan-McDermid-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -305577,7 +305124,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="3">
+      <PrevalenceList count="6">
         <Prevalence id="5655">
           <Source>19170813[PMID]</Source>
           <PrevalenceType id="23676">
@@ -305635,6 +305182,63 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17534">
+          <Source>19170813[PMID]_30252369[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="de">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.3</ValMoy>
+          <PrevalenceGeographic id="24418">
+            <Name lang="de">Germany</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17535">
+          <Source>15569006[PMID]_30252369[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="de">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.207</ValMoy>
+          <PrevalenceGeographic id="24677">
+            <Name lang="de">Kuwait</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17536">
+          <Source>12207586[PMID]_23237497[PMID]_30252369[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.078</ValMoy>
+          <PrevalenceGeographic id="25244">
+            <Name lang="de">Singapore</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="10596">
@@ -310033,14 +309637,14 @@
     <Disorder id="11998">
       <OrphaCode>90285</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=90285</ExpertLink>
-      <Name lang="de">Lupus-Pannikulitis</Name>
+      <Name lang="de">Lupus erythematodes Pannikulitis</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="10704">
           <Source>19289752[PMID]</Source>
           <PrevalenceType id="23676">
@@ -310060,6 +309664,25 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17553">
+          <Source>9918242[PMID]_19289752[PMID]_30658703[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="de">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.315</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="de">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="11997">
@@ -312424,7 +312047,7 @@
     <Disorder id="11778">
       <OrphaCode>86900</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=86900</ExpertLink>
-      <Name lang="de">Sarkom der interdigitierenden dendritischen Zellen</Name>
+      <Name lang="de">Interdigitierendes dendritisches Zellsarkom</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -313552,7 +313175,7 @@
     <Disorder id="12205">
       <OrphaCode>93262</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=93262</ExpertLink>
-      <Name lang="de">Crouzon-Syndrom - Acanthosis nigricans</Name>
+      <Name lang="de">Crouzon-Syndrom-Acanthosis nigricans-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -313706,7 +313329,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="11352">
           <Source>12769508[PMID]</Source>
           <PrevalenceType id="23683">
@@ -313726,6 +313349,25 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17564">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="25468">
+            <Name lang="de">United Arab Emirates</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="12212">
@@ -314768,7 +314410,7 @@
     <Disorder id="12259">
       <OrphaCode>93322</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=93322</ExpertLink>
-      <Name lang="de">Tibia-Hemimelie</Name>
+      <Name lang="de">Tibia-Hemimelie, isolierte</Name>
       <DisorderType id="21415">
         <Name lang="de">Morphologische Anomalie</Name>
       </DisorderType>
@@ -314819,7 +314461,7 @@
     <Disorder id="12258">
       <OrphaCode>93321</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=93321</ExpertLink>
-      <Name lang="de">Hemimelie, radiale</Name>
+      <Name lang="de">Hemimelie, isolierte radiale</Name>
       <DisorderType id="21415">
         <Name lang="de">Morphologische Anomalie</Name>
       </DisorderType>
@@ -314870,7 +314512,7 @@
     <Disorder id="12257">
       <OrphaCode>93320</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=93320</ExpertLink>
-      <Name lang="de">Hemimelie, ulnare</Name>
+      <Name lang="de">Hemimelie, isolierte ulnare</Name>
       <DisorderType id="21415">
         <Name lang="de">Morphologische Anomalie</Name>
       </DisorderType>
@@ -314902,7 +314544,7 @@
     <Disorder id="12260">
       <OrphaCode>93323</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=93323</ExpertLink>
-      <Name lang="de">Hemimelie, fibuläre</Name>
+      <Name lang="de">Hemimelie, fibuläre isolierte</Name>
       <DisorderType id="21415">
         <Name lang="de">Morphologische Anomalie</Name>
       </DisorderType>
@@ -315009,7 +314651,26 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17555">
+          <Source>31091006[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="de">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>43.5</ValMoy>
+          <PrevalenceGeographic id="24845">
+            <Name lang="de">Mexico</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="16278">
           <Source>31091006[PMID]</Source>
           <PrevalenceType id="23683">
@@ -315041,7 +314702,26 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17554">
+          <Source>31091006[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="de">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>15.7</ValMoy>
+          <PrevalenceGeographic id="24845">
+            <Name lang="de">Mexico</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="16277">
           <Source>31091006[PMID]</Source>
           <PrevalenceType id="23683">
@@ -316160,7 +315840,64 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="3">
+      <PrevalenceList count="6">
+        <Prevalence id="17531">
+          <Source>22966025[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="24124">
+            <Name lang="de">Canada</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17532">
+          <Source>15858962[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="24264">
+            <Name lang="de">Denmark</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17533">
+          <Source>15466085[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="de">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="14604">
           <Source>22966025[PMID]</Source>
           <PrevalenceType id="23683">
@@ -316262,7 +315999,26 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17568">
+          <Source>32021624[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="25475">
+            <Name lang="de">United Kingdom</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="14607">
           <Source>17074786[PMID]</Source>
           <PrevalenceType id="23683">
@@ -319728,7 +319484,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="4">
         <Prevalence id="6521">
           <Source>31920360[PMID]</Source>
           <PrevalenceType id="23683">
@@ -319767,6 +319523,44 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17520">
+          <Source>31920360[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="de">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.963</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="de">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17541">
+          <Source>31920360[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="de">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.2222</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="de">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="11437">
@@ -320019,7 +319813,7 @@
     <Disorder id="11483">
       <OrphaCode>79457</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=79457</ExpertLink>
-      <Name lang="de">Urticaria pigmentosa</Name>
+      <Name lang="de">Mastozytose, kutane makulopapuläre</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -321173,368 +320967,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="11290">
-      <OrphaCode>79264</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=79264</ExpertLink>
-      <Name lang="de">Ceroid-Lipofuszinose, neuronale, juvenile</Name>
-      <DisorderType id="21394">
-        <Name lang="de">Krankheit</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="10">
-        <Prevalence id="10746">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.46</ValMoy>
-          <PrevalenceGeographic id="25335">
-            <Name lang="de">Sweden</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10747">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="de">Prävalenz bei Geburt</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="de">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>2.2</ValMoy>
-          <PrevalenceGeographic id="25335">
-            <Name lang="de">Sweden</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10748">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="de">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.22</ValMoy>
-          <PrevalenceGeographic id="24362">
-            <Name lang="de">Finland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10749">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="de">Prävalenz bei Geburt</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="de">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>4.8</ValMoy>
-          <PrevalenceGeographic id="24362">
-            <Name lang="de">Finland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10750">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.65</ValMoy>
-          <PrevalenceGeographic id="25006">
-            <Name lang="de">Norway</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10751">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="de">Prävalenz bei Geburt</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="de">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>3.7</ValMoy>
-          <PrevalenceGeographic id="25006">
-            <Name lang="de">Norway</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10752">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="de">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.1</ValMoy>
-          <PrevalenceGeographic id="24551">
-            <Name lang="de">Iceland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10753">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="de">Prävalenz bei Geburt</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="de">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>7.0</ValMoy>
-          <PrevalenceGeographic id="24551">
-            <Name lang="de">Iceland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10754">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.31</ValMoy>
-          <PrevalenceGeographic id="24264">
-            <Name lang="de">Denmark</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10755">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="de">Prävalenz bei Geburt</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="de">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>2.0</ValMoy>
-          <PrevalenceGeographic id="24264">
-            <Name lang="de">Denmark</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
-    <Disorder id="11289">
-      <OrphaCode>79263</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=79263</ExpertLink>
-      <Name lang="de">Ceroid-Lipofuszinose, neuronale, infantile</Name>
-      <DisorderType id="21394">
-        <Name lang="de">Krankheit</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="6">
-        <Prevalence id="6367">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="de">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10741">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.07</ValMoy>
-          <PrevalenceGeographic id="25335">
-            <Name lang="de">Sweden</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10742">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="de">Prävalenz bei Geburt</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.6</ValMoy>
-          <PrevalenceGeographic id="25335">
-            <Name lang="de">Sweden</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10743">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.54</ValMoy>
-          <PrevalenceGeographic id="24362">
-            <Name lang="de">Finland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10744">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="de">Prävalenz bei Geburt</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="de">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>5.0</ValMoy>
-          <PrevalenceGeographic id="24362">
-            <Name lang="de">Finland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10745">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.02</ValMoy>
-          <PrevalenceGeographic id="25006">
-            <Name lang="de">Norway</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
-    <Disorder id="11288">
-      <OrphaCode>79262</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=79262</ExpertLink>
-      <Name lang="de">Ceroid-Lipofuszinose, neuronale, adulte</Name>
-      <DisorderType id="21394">
-        <Name lang="de">Krankheit</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="6366">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="de">Unbekannt</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="11295">
       <OrphaCode>79269</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=79269</ExpertLink>
@@ -321876,7 +321308,45 @@
       <DisorderGroup id="36554">
         <Name lang="de">Subtyp der Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="4">
+        <Prevalence id="17518">
+          <Source>32024337[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="de">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>6.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17519">
+          <Source>32024337[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="de">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>6.34</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="de">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="17122">
           <Source>32024337[PMID]</Source>
           <PrevalenceType id="23683">
@@ -330175,7 +329645,7 @@
     <Disorder id="11725">
       <OrphaCode>85458</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=85458</ExpertLink>
-      <Name lang="de">Hereditäre zerebrale Hämorrhagie mit Amyloidose</Name>
+      <Name lang="de">Amyloidangiopathie, zerebrale</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -330421,11 +329891,11 @@
       <OrphaCode>85447</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=85447</ExpertLink>
       <Name lang="de">ATTRV30M-Amyloidose</Name>
-      <DisorderType id="21394">
-        <Name lang="de">Krankheit</Name>
+      <DisorderType id="21450">
+        <Name lang="de">Klinischer Subtyp</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
+      <DisorderGroup id="36554">
+        <Name lang="de">Subtyp der Störung</Name>
       </DisorderGroup>
       <PrevalenceList count="8">
         <Prevalence id="6831">
@@ -330586,11 +330056,11 @@
       <OrphaCode>85451</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=85451</ExpertLink>
       <Name lang="de">ATTRV122I-Amyloidose</Name>
-      <DisorderType id="21394">
-        <Name lang="de">Krankheit</Name>
+      <DisorderType id="21450">
+        <Name lang="de">Klinischer Subtyp</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
+      <DisorderGroup id="36554">
+        <Name lang="de">Subtyp der Störung</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="6841">
@@ -330781,7 +330251,7 @@
     <Disorder id="11728">
       <OrphaCode>86789</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=86789</ExpertLink>
-      <Name lang="de">Patella-Aplasie/-Hypoplasie</Name>
+      <Name lang="de">Patella-Aplasie/Hypoplasie, isolierte</Name>
       <DisorderType id="21415">
         <Name lang="de">Morphologische Anomalie</Name>
       </DisorderType>
@@ -331303,7 +330773,7 @@
     <Disorder id="11749">
       <OrphaCode>86839</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=86839</ExpertLink>
-      <Name lang="de">Refraktäre Anämie mit Blastenexzess</Name>
+      <Name lang="de">Myelodysplastische Neoplasie mit erhöhtem Blastenanteil</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -331883,7 +331353,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="11975">
           <Source>European Medicines Agency 2015[INST]</Source>
           <PrevalenceType id="23669">
@@ -331903,6 +331373,25 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17475">
+          <Source>36946176[PMID]</Source>
+          <PrevalenceType id="23676">
+            <Name lang="de">Jahresinzidenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.03</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="de">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="11765">
@@ -336708,7 +336197,7 @@
     <Disorder id="11640">
       <OrphaCode>85173</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=85173</ExpertLink>
-      <Name lang="de">IMAGE-Syndrom</Name>
+      <Name lang="de">IMAGe-Syndrom</Name>
       <DisorderType id="21401">
         <Name lang="de">Fehlbildungs-Syndrom</Name>
       </DisorderType>
@@ -337046,6 +336535,136 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="30613">
+      <OrphaCode>603448</OrphaCode>
+      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=603448</ExpertLink>
+      <Name lang="de">Zerebelläre Hypoplasie-Intelligenzminderung-kongenitale Mikrozephalie-Dystonie-Anämie-Wachstumsstörung-Syndrom</Name>
+      <DisorderType id="21401">
+        <Name lang="de">Fehlbildungs-Syndrom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="de">Störung</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17486">
+          <Source>33186543[PMID]_33186545[PMID]_33460484[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="de">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="de">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>10.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17487">
+          <Source>33186543[PMID]_33186545[PMID]_33460484[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="30615">
+      <OrphaCode>603515</OrphaCode>
+      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=603515</ExpertLink>
+      <Name lang="de">Isolierte weibliche Hypospadie</Name>
+      <DisorderType id="21415">
+        <Name lang="de">Morphologische Anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="de">Störung</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17490">
+          <Source>31105404[PMID]</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="30614">
+      <OrphaCode>603494</OrphaCode>
+      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=603494</ExpertLink>
+      <Name lang="de">Kolobom-Osteopetrose-Mikrophthalmie-Makrozephalie-Albinismus-Schwerhörigkeit-Syndrom</Name>
+      <DisorderType id="21401">
+        <Name lang="de">Fehlbildungs-Syndrom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="de">Störung</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17488">
+          <Source>27889061[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="de">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="de">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>2.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17489">
+          <Source>27889061[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="30617">
       <OrphaCode>603689</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=603689</ExpertLink>
@@ -337144,6 +336763,349 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="30683">
+      <OrphaCode>610569</OrphaCode>
+      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=610569</ExpertLink>
+      <Name lang="de">KIAA1109-assoziierte früh-letale kongenitale Hirnfehlbildungen-Arthrogrypose-Syndrom</Name>
+      <DisorderType id="21394">
+        <Name lang="de">Krankheit</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="de">Störung</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17499">
+          <Source>29290337[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="de">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="de">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>13.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17500">
+          <Source>29290337[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="30663">
+      <OrphaCode>604680</OrphaCode>
+      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=604680</ExpertLink>
+      <Name lang="de">Symptomatische Form der X-chromosomalen zentronukleären Myopathie bei weiblichen Anlageträgerinnen</Name>
+      <DisorderType id="21394">
+        <Name lang="de">Krankheit</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="de">Störung</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17491">
+          <Source>28685322[PMID]_34011573[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23697">
+            <Name lang="de">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="de">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>100.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17492">
+          <Source>28685322[PMID]_34011573[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="30694">
+      <OrphaCode>611256</OrphaCode>
+      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=611256</ExpertLink>
+      <Name lang="de">Pontozerebelläre Hypoplasie Typ 12</Name>
+      <DisorderType id="21401">
+        <Name lang="de">Fehlbildungs-Syndrom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="de">Störung</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17507">
+          <Source>30089828[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="de">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="de">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>4.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17508">
+          <Source>30089828[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="30692">
+      <OrphaCode>611237</OrphaCode>
+      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=611237</ExpertLink>
+      <Name lang="de">Parkinsonismus mit Polyneuropathie</Name>
+      <DisorderType id="21394">
+        <Name lang="de">Krankheit</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="de">Störung</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17501">
+          <Source>33141179[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="de">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="de">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>4.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17502">
+          <Source>33141179[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="30693">
+      <OrphaCode>611247</OrphaCode>
+      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=611247</ExpertLink>
+      <Name lang="de">Pontozerebelläre Hypoplasie Typ 11</Name>
+      <DisorderType id="21401">
+        <Name lang="de">Fehlbildungs-Syndrom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="de">Störung</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17505">
+          <Source>28823707[PMID]_28823706[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="de">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="de">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>13.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17506">
+          <Source>28823707[PMID]_28823706[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="30688">
+      <OrphaCode>611201</OrphaCode>
+      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=611201</ExpertLink>
+      <Name lang="de">Syndrom der okulo-gastro-intestinalen neurologische Entwicklungsstörungen</Name>
+      <DisorderType id="21401">
+        <Name lang="de">Fehlbildungs-Syndrom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="de">Störung</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17497">
+          <Source>32885237[PMID]_33410501[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="de">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="de">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>7.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17498">
+          <Source>32885237[PMID]_33410501[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="30702">
+      <OrphaCode>613267</OrphaCode>
+      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=613267</ExpertLink>
+      <Name lang="de">Pontozerebelläre Hypoplasie Typ 13</Name>
+      <DisorderType id="21401">
+        <Name lang="de">Fehlbildungs-Syndrom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="de">Störung</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17509">
+          <Source>30624672[PMID]_31207318[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="de">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="de">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>3.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17510">
+          <Source>30624672[PMID]_31207318[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="13103">
       <OrphaCode>98085</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=98085</ExpertLink>
@@ -337195,6 +337157,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="30703">
+      <OrphaCode>613274</OrphaCode>
+      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=613274</ExpertLink>
+      <Name lang="de">Pontozerebelläre Hypoplasie Typ 14</Name>
+      <DisorderType id="21401">
+        <Name lang="de">Fehlbildungs-Syndrom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="de">Störung</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17503">
+          <Source>33220177[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="de">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="de">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>18.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17504">
+          <Source>33220177[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="13266">
       <OrphaCode>98249</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=98249</ExpertLink>
@@ -339886,7 +339897,26 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17556">
+          <Source>9562017[PMID]_25752370[PMID]_34631807[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="24369">
+            <Name lang="de">France</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="13182">
           <Source>8308205[PMID]</Source>
           <PrevalenceType id="23683">
@@ -340854,7 +340884,7 @@
     <Disorder id="12857">
       <OrphaCode>97230</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=97230</ExpertLink>
-      <Name lang="de">Sonnenurtikaria</Name>
+      <Name lang="de">Licht-Urtikaria</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -341325,7 +341355,26 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17521">
+          <Source>20301604[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="de">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>8.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="13481">
           <Source>20301604[PMID]</Source>
           <PrevalenceType id="23683">
@@ -341516,7 +341565,7 @@
     <Disorder id="12666">
       <OrphaCode>95711</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=95711</ExpertLink>
-      <Name lang="de">Schilddrüsen-Dysgenesie</Name>
+      <Name lang="de">Kongenitale Hypothyreose durch Entwicklungsanomalie</Name>
       <DisorderType id="36561">
         <Name lang="de">Kategorie</Name>
       </DisorderType>
@@ -341712,7 +341761,7 @@
     <Disorder id="12650">
       <OrphaCode>95626</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=95626</ExpertLink>
-      <Name lang="de">Zentraler Diabetes insipidus, erworbener</Name>
+      <Name lang="de">Arginin-Vasopressin-Mangel, erworbener</Name>
       <DisorderType id="21450">
         <Name lang="de">Klinischer Subtyp</Name>
       </DisorderType>
@@ -342075,38 +342124,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="12581">
-      <OrphaCode>95161</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=95161</ExpertLink>
-      <Name lang="de">Porphyrie, chronische hepatische</Name>
-      <DisorderType id="21436">
-        <Name lang="de">Phenom-Gruppe</Name>
-      </DisorderType>
-      <DisorderGroup id="36540">
-        <Name lang="de">Gruppe von Störungen</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="7322">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="de">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="de">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="12580">
       <OrphaCode>95159</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=95159</ExpertLink>
@@ -344844,7 +344861,45 @@
       <DisorderGroup id="36554">
         <Name lang="de">Subtyp der Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="4">
+        <Prevalence id="17544">
+          <Source>4250044[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="de">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.2</ValMoy>
+          <PrevalenceGeographic id="24124">
+            <Name lang="de">Canada</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17545">
+          <Source>18796143[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="de">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.07</ValMoy>
+          <PrevalenceGeographic id="25475">
+            <Name lang="de">United Kingdom</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="12440">
           <Source>4250044[PMID]</Source>
           <PrevalenceType id="23683">
@@ -346085,8 +346140,8 @@
           <PrevalenceType id="23669">
             <Name lang="de">Punktprävalenz</Name>
           </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
           </PrevalenceQualification>
           <PrevalenceClass id="23760">
             <Name lang="de">&lt;1 / 1 000 000</Name>
@@ -347024,7 +347079,7 @@
     <Disorder id="12538">
       <OrphaCode>94056</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=94056</ExpertLink>
-      <Name lang="de">Synostose, humero-ulnare</Name>
+      <Name lang="de">Synostose, humero-ulnare isolierte</Name>
       <DisorderType id="21415">
         <Name lang="de">Morphologische Anomalie</Name>
       </DisorderType>
@@ -349468,7 +349523,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="4">
         <Prevalence id="7778">
           <Source>18657826[PMID]</Source>
           <PrevalenceType id="23683">
@@ -349507,6 +349562,44 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17522">
+          <Source>12084585[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="de">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>9.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17542">
+          <Source>18657826[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="de">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>8.0</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="de">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="14112">
@@ -349920,38 +350013,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="14220">
-      <OrphaCode>99647</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=99647</ExpertLink>
-      <Name lang="de">Cheiro-spondylo-enchondromatose</Name>
-      <DisorderType id="21394">
-        <Name lang="de">Krankheit</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="12060">
-          <Source>ORPHANET_20661403[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="de">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="14219">
       <OrphaCode>99646</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=99646</ExpertLink>
@@ -350517,14 +350578,16 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="16630">
-          <Source>PMID: 26882032</Source>
+          <Source>26882032[PMID]</Source>
           <PrevalenceType id="23669">
             <Name lang="de">Punktprävalenz</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23711">
             <Name lang="de">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass/>
+          <PrevalenceClass id="23746">
+            <Name lang="de">1-9 / 100 000</Name>
+          </PrevalenceClass>
           <ValMoy>1.29</ValMoy>
           <PrevalenceGeographic id="24607">
             <Name lang="de">Italy</Name>
@@ -352781,7 +352844,7 @@
     <Disorder id="13843">
       <OrphaCode>98826</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=98826</ExpertLink>
-      <Name lang="de">Anämie, refraktäre</Name>
+      <Name lang="de">Myelodysplastische Neoplasie mit niedrigem Blastenanteil</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -358963,7 +359026,7 @@
     <Disorder id="13924">
       <OrphaCode>98907</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=98907</ExpertLink>
-      <Name lang="de">Neutrale Lipidspeicherkrankheit mit Ichthyose</Name>
+      <Name lang="de">Neutralfett-Speicherkrankheit mit Ichthyose</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -359215,7 +359278,7 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="7726">
           <Source>11826019[PMID]</Source>
           <PrevalenceType id="23683">
@@ -359235,6 +359298,25 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17557">
+          <Source>11826019[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="de">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="de">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>19.0</ValMoy>
+          <PrevalenceGeographic id="25475">
+            <Name lang="de">United Kingdom</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="13966">
@@ -360072,55 +360154,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="13992">
-      <OrphaCode>98975</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=98975</ExpertLink>
-      <Name lang="de">Endotheldystrophie, hereditäre kongenitale 1</Name>
-      <DisorderType id="21394">
-        <Name lang="de">Krankheit</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="7755">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23697">
-            <Name lang="de">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="de">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>68.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="7756">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="de">Punktprävalenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="de">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="13993">
       <OrphaCode>98976</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=98976</ExpertLink>
@@ -362514,9 +362547,9 @@
       <DisorderGroup id="36547">
         <Name lang="de">Störung</Name>
       </DisorderGroup>
-      <PrevalenceList count="3">
+      <PrevalenceList count="4">
         <Prevalence id="16542">
-          <Source>PMID: 18720461; 25917534</Source>
+          <Source>18720461[PMID]_25917534[PMID]</Source>
           <PrevalenceType id="23676">
             <Name lang="de">Jahresinzidenz</Name>
           </PrevalenceType>
@@ -362535,7 +362568,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="16543">
-          <Source>PMID: 25917534</Source>
+          <Source>25917534[PMID]</Source>
           <PrevalenceType id="23676">
             <Name lang="de">Jahresinzidenz</Name>
           </PrevalenceType>
@@ -362554,7 +362587,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="16544">
-          <Source>PMID: 18720461</Source>
+          <Source>18720461[PMID]</Source>
           <PrevalenceType id="23676">
             <Name lang="de">Jahresinzidenz</Name>
           </PrevalenceType>
@@ -362572,6 +362605,25 @@
             <Name lang="de">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17526">
+          <Source>18720461[PMID]_25917534[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="de">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="13732">
@@ -364116,7 +364168,7 @@
     <Disorder id="28919">
       <OrphaCode>580572</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=580572</ExpertLink>
-      <Name lang="de">Intraduktale papilläre Neoplasien der Gallenwege</Name>
+      <Name lang="de">Intraduktale tubulopapilläre Neoplasie des Pankreas</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -365468,7 +365520,7 @@
     <Disorder id="13514">
       <OrphaCode>98497</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=98497</ExpertLink>
-      <Name lang="de">Nervenkrankheit, periphere, genetisch bedingte</Name>
+      <Name lang="de">Neuropathie, periphere, genetisch bedingte</Name>
       <DisorderType id="36561">
         <Name lang="de">Kategorie</Name>
       </DisorderType>
@@ -367484,266 +367536,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="14807">
-      <OrphaCode>101096</OrphaCode>
-      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=101096</ExpertLink>
-      <Name lang="de">Anämie, aregenerative</Name>
-      <DisorderType id="21394">
-        <Name lang="de">Krankheit</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="de">Störung</Name>
-      </DisorderGroup>
-      <PrevalenceList count="13">
-        <Prevalence id="16820">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23676">
-            <Name lang="de">Jahresinzidenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.3312</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="de">Weltweit</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16821">
-          <Source>2183887[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="de">Jahresinzidenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.15</ValMoy>
-          <PrevalenceGeographic id="24369">
-            <Name lang="de">France</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16822">
-          <Source>18322256[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="de">Jahresinzidenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.234</ValMoy>
-          <PrevalenceGeographic id="25293">
-            <Name lang="de">Spain</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16823">
-          <Source>28751565[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="de">Jahresinzidenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.235</ValMoy>
-          <PrevalenceGeographic id="25335">
-            <Name lang="de">Sweden</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16824">
-          <Source>1813058[PMID]_31091521[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="de">Jahresinzidenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.535</ValMoy>
-          <PrevalenceGeographic id="24166">
-            <Name lang="de">China</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16825">
-          <Source>30178191[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="de">Jahresinzidenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.567</ValMoy>
-          <PrevalenceGeographic id="25356">
-            <Name lang="de">Taiwan, Province of China</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16826">
-          <Source>10398308[PMID]_34269837[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="de">Jahresinzidenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.425</ValMoy>
-          <PrevalenceGeographic id="25377">
-            <Name lang="de">Thailand</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16827">
-          <Source>10968139[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="de">Jahresinzidenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.48</ValMoy>
-          <PrevalenceGeographic id="24782">
-            <Name lang="de">Malaysia</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16828">
-          <Source>31906834[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="de">Jahresinzidenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.35</ValMoy>
-          <PrevalenceGeographic id="25020">
-            <Name lang="de">Pakistan</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16829">
-          <Source>19734415[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="de">Jahresinzidenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.119</ValMoy>
-          <PrevalenceGeographic id="23928">
-            <Name lang="de">Argentina</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16830">
-          <Source>19734415[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="de">Jahresinzidenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.217</ValMoy>
-          <PrevalenceGeographic id="24068">
-            <Name lang="de">Brazil</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16831">
-          <Source>19734415[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="de">Jahresinzidenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="de">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0063</ValMoy>
-          <PrevalenceGeographic id="24845">
-            <Name lang="de">Mexico</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16832">
-          <Source>30592075[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="de">Jahresinzidenz</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="de">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="de">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.6</ValMoy>
-          <PrevalenceGeographic id="25370">
-            <Name lang="de">Tanzania, United Republic of</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="de">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="14752">
       <OrphaCode>101041</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=101041</ExpertLink>
@@ -370398,7 +370190,7 @@
     <Disorder id="14593">
       <OrphaCode>100020</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=100020</ExpertLink>
-      <Name lang="de">Anämie, refraktäre, mit Blastenexzess-2</Name>
+      <Name lang="de">Myelodysplastische Neoplasie mit erhöhtem Blastenanteil Typ 2</Name>
       <DisorderType id="21450">
         <Name lang="de">Klinischer Subtyp</Name>
       </DisorderType>
@@ -370430,7 +370222,7 @@
     <Disorder id="14592">
       <OrphaCode>100019</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=100019</ExpertLink>
-      <Name lang="de">Anämie, refraktäre, mit Blastenexzess-1</Name>
+      <Name lang="de">Myelodysplastische Neoplasie mit erhöhtem Blastenanteil Typ 1</Name>
       <DisorderType id="21450">
         <Name lang="de">Klinischer Subtyp</Name>
       </DisorderType>
@@ -373855,7 +373647,7 @@
     <Disorder id="14485">
       <OrphaCode>99912</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=99912</ExpertLink>
-      <Name lang="de">Maligner dysgerminomatöser Keimzelltumor des Ovars</Name>
+      <Name lang="de">Dysgerminom des Ovars</Name>
       <DisorderType id="21394">
         <Name lang="de">Krankheit</Name>
       </DisorderType>
@@ -376347,6 +376139,70 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31322">
+      <OrphaCode>615970</OrphaCode>
+      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=615970</ExpertLink>
+      <Name lang="de">Chronische Intervillositis unbekannter Ätiologie</Name>
+      <DisorderType id="21394">
+        <Name lang="de">Krankheit</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="de">Störung</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17494">
+          <Source>32841927[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31346">
+      <OrphaCode>617408</OrphaCode>
+      <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=617408</ExpertLink>
+      <Name lang="de">Klassische eosinophile pustulöse Follikulitis</Name>
+      <DisorderType id="21394">
+        <Name lang="de">Krankheit</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="de">Störung</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17493">
+          <Source>37983361[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="de">Punktprävalenz</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="de">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="de">Unbekannt</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="de">Weltweit</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="de">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="31468">
       <OrphaCode>623789</OrphaCode>
       <ExpertLink lang="de">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=de&amp;Expert=623789</ExpertLink>
